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The repair and management of full-thickness skin defects such as those resulting from 
burns and chronic wounds remains a significant challenge. The shortage of donor sites makes it 
impractical to treat with autologous skin grafts for defects exceeding 50-60% of the total skin 
area. Thus, the most promising approach for the repair of full thickness wound is using a tissue-
engineered skin graft with the primary goal is to restore lost barrier function. However, 
regeneration of appendages like hair follicles and sebaceous glands has not yet been achieved. 
Previously, we have shown that maintaining WJMSCs seeded onto DWJM in osteogenic media 
induces ectodermal differentiation evident by generating CK 19 positive cells. WJMSCs are 
easily accessible non-controversial source of MSCs with self-renewal ability and extended 
proliferation potential, making them excellent candidates for tissue engineering. This dissertation 
presents a novel method to promote complete skin regeneration. To achieve this, we 
ectodermally differentiate Wharton’s jelly mesenchymal stem cells (WJMSCs) by seeding these 
cells onto a three-dimensional decellularized Wharton’s jelly matrix (DWJM) and maintaining 
them in osteogenic differentiation (OD) media. The combination of WJMSCs, DWJM, an 
acellular dermal graft (DG) (Alloderm®) and the ectodermally differentiated cells were 
investigated in a wound healing mouse model. The extraction, characterization and use of 
DWJM in skin tissue engineering as a bioactive, biocompatible and biodegradable scaffold were 
demonstrated. WJMSCs cultured on DWJM or DG in both regular and OD media generated 
cytokeratin19 (CK19), collagen I, and alpha-smooth muscle actin (αSMA) positive cells 
demonstrating ectodermal differentiation. Further, hair-like structures were generated only when 
WJMSCs were cultured in OD media on DWJM. We explored the underlying molecular 
mechanisms for ectodermal differentiation in our model and observed up-regulation of β-catenin, 
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noggin, VCAN, and SMAD genes. Mice with full thickness wounds when transplanted with in 
vitro differentiated/undifferentiated WJMSCs on DWJM demonstrated no skin regeneration. 
However, mice transplanted with in vitro differentiated WJMSCs on DG demonstrated complete 
skin regeneration along with skin appendages like hair follicles and sebaceous glands.  Further, 
the combination of DWJM and DG with in vitro differentiated WJMSCs also showed complete 
skin regeneration but skin appendages were not as developed.  Thus, this current dissertation 
demonstrates the use of differentiated WJMSCs in combination with DWJM and DG as a novel 
approach for complete skin regeneration of full thickness wounds in a mouse model. 
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Chapter 1: Introduction 
A full-thickness wound to a complex tissue such has skin, results in damage to many 
structures, cell layers and all lineages. A wound could damage the outermost epidermal 
keratinocyte layer with its associated epidermal components such as hair follicles, sweat glands, 
the underlying basement membrane, and the dermis which is comprised of fibroblasts, 
extracellular matrix, nerves, blood and lymphatic systems [1].  Wounds could be caused by 
trauma, medical conditions, and burn among others. According to the Centers for disease control 
and prevention, burns and fires are the third leading cause of death at home. In 2010, a fire injury 
occurred every 30 minutes, while a fire-related death occurred every 169 minutes [2]. As per the 
American burn association, about 450,000 patients receive treatment in hospitals and emergency 
rooms each year. Forty four percent of burn center admissions are a result of fire, while 33 
percent are scalding injuries resulting from wet or moist heat and 9 percent from contact with a 
hot source, 4 percent are electric burns, 3 percent are chemical burns and the remaining 7 percent 
are due to other miscellaneous sources like vehicle crashes etc. [3]. Burn and fire hospitalizations 
in the US cost $1billion per year, while non-hospitalized burn and fire injuries cost $3 billion. 
Although burns differ from other wounds in the degree of systemic inflammation, the healing 
and repair of burns is an essential dynamic physiological process required for maintaining tissue 
homeostasis. Healing and management of full-thickness wounds is a dynamic, complicated, and 
coordinated series of hemostasis, inflammation, and proliferation/granulation and matrix 
formation/remodeling.  
Wound Healing 




Hemostasis is the immediate response to a skin wound, where damaged and stressed cells 
activate stress signal pathways such as SAP/JNK and p38, which result in phosphorylation of a 
cascade of signaling molecules that can alter gene expression, cell survival and metabolism [4, 
5]. The damage to blood vessels is combated by platelet activation and aggregation and fibrin 
clot formation. Several growth factors such as platelet derived growth factor, CXCL4, basic 
fibroblast growth factor, vascular endothelial growth factor and transforming growth factor – β 
are released into the serum and several interleukins, TNF-α, Interferon-γ to induce transcription 
of immediate and early genes to assist with the repair process including angiogenesis, 
inflammation and migration of keratinocytes and fibroblasts [6].  
Inflammatory response 
The inflammatory response to wounding begins with passive leakage of circulating 
leukocytes such as neutrophils from damaged blood vessels into the wound. Immune cells such 
as mast cells [7], and Langerhans cells [8] are released which in turn release a variety of 
chemokines and cytokines. Neutrophils and macrophages are also recruited to trigger local 
endothelial cell activation followed by tethering of leukocytes to the vessel wall [9, 10].  
Angiogenesis 
Angiogenesis involves sprouting of wound-edge capillaries followed by their invasion 
into the site of damage which helps in formation of new micro-vascular networks throughout the 
wound to provide nutrients and oxygen to the growing tissues and aid in the formation of 
provisional wound matrix, also known as granulation tissue [11]. A clot/scab is formed as a 
temporary mechanism to restore the function by acting as a protective barrier to skin.  The 
proliferation, migration and contraction are the final mechanism that the body adopts to close the 
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wound gap and replenish lost tissue. This process is initiated within hours, but the time required 
to heal is highly variable and depends on size and location of wound as well as on the age and 
health of tissue.  
Re-epithelialization 
Re-epithelialization of a wound begins with cell-cell and cell-matrix adhesions between 
keratinocytes, fibroblasts and the surrounding stem cells from the epidermis and bulge region of 
hair follicles [12]. These enable deposition of matrix proteins such as laminin V, fibronectin and 
collagen IV that help in regenerating an epidermis [13-15]. The fibroblasts and myofibroblasts 
from the close vicinity of wound respond by forming weakly contractile actin bundles, which 
enable connective tissue contraction, and synthesis, bundling collagen fibers thereby, 
constituting the primary scar tissue and dermis [16, 17].  
Remodeling 
During the final stage, blood vessels within the scar are refined and mature to form a 
functional network [18]. The dense extracellular matrix is remodeled to restore normal 
architecture to dermis through collagen synthesis, bundling and degradation. Neutrophils are 
cleared by apoptosis and subsequent phagocytosis by macrophages [19]. Imperfect regulation of 
wound resolution can result in hyper-proliferation, persistence of inflammatory reaction, fibrosis 
and excessive scar formation [20].  
The treatment of patients with severe burn exceeding 50-60% of the total body surface 
area such massive deep burns or chronic ulcers, has been the biggest challenge despite of 
refinements in burn shock resuscitation, improvements in surgical techniques, advances in 
intensive care medicine and the availability of expert surgeons [21].  A major problem associated 
with the treatment of these burns injuries is the limited availability of autologous skin for 
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transplantation and the creation of additional donor site morbidity [21].  Harvesting a split 
thickness skin graft with epidermis and a part of dermis is a viable possibility, but this could lead 
to keloid formation and increased scarring, especially in children [22].  
Natural Scaffold Materials in Skin Repair and Wound Healing  
To assist in wound healing, there are variety of naturally obtained scaffold materials such 
as collagen, gelatin, silk fibroin, fibrin and elastin along with polysaccharide polymers like 
chitosan, starch, alginate, hyaluronan, chondroitin sulphate that can assist in the process of 
wound healing and skin regeneration.  
Collagen is regarded as an ideal scaffold as it is a major protein component of 
extracellular matrix, providing support and transducing essential signals for regulation of cell 
anchorage, migration, proliferation and differentiation for connective tissues like skin, tendons, 
bones, cartilage, blood vessels and ligaments [23-26]. Collagen also has high mechanical 
strength, good biocompatibility, and low antigenicity and is easily cross-linked [23]. Apligraf® 
(Organogenesis, USA) is a bi-layered collagen gel seeded with human fibroblasts in the lower 
part and human keratinocytes in the upper layer and is being used as a dermal matrix for artificial 
skin. Although collagen has some great applications, it also linked with some disadvantages such 
as sterilization drawbacks, difficulty in processing, disability to control the rate of degradability 
and also the potential for viral and prion contamination since they are derived from animals and 
the associated high cost of purification techniques [27]. 
Gelatin is a natural polymer derived from collagen and is commonly used as a carrier for 
drug delivery and tissue engineering applications due to its biodegradability, biocompatibility 
and the possibility of poly-ion complexation. Ito et al. developed a novel biodegradable hydrogel 
by cross-linking gelatin with transglutaminase (TGase) in an aqueous solution. They showed that 
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incorporating cell adhesion factors like vitronectin, fibronectin and two RGD peptides  - 
RGDLLQ and RGDLLG in the hydrogels enhanced proliferation of NIH3T3 fibroblasts and this 
biomaterial can be used for wound dressing and tissue engineering applications[28].  
Silk Fibroin is a protein polymer from Lepidoptera larvae such as silkworms, spiders, 
scorpions, mites and flies, which are spun into fibers [29]. These fibers are light in weight, 
extremely strong, and are an excellent biomaterial because of their biocompatibility [30, 31], 
slow biodegradability [32] and great mechanical properties. Min et al. developed an electro 
spinning method to fabricate silk fibroin nano-fiber nonwovens for cell culture of normal human 
keratinocytes and fibroblasts and showed that these fibers are a good candidate for tissue 
engineering and wound dressing applications [33].  
Fibrin is a protein matrix produced from fibrinogen, which can be autologously 
harvested from the patient [34]. Fibrin glue is a biological adhesive used in abdominal, thoracic, 
vascular, oral and endoscopic surgeries due its hemostatic, chemotactic and mitogenic 
properties[35]. Neidert et al. developed scaffolds of fibrin gels with entrapped tissue cells to 
improve collagen content and enhance mechanical properties to develop robust fibrin based 
tissue equivalents for soft connective tissue applications [36].  
There are also other protein-based biopolymers such as elastin and soybean, which have 
been used as scaffolds in tissue engineering. Elastin is an extracellular matrix protein deposited 
in the arterial wall and synthesized by vascular smooth muscle cells and secreted as a 
tropoelastin monomer that is soluble, non-glycosylated and highly hydrophobic [37]. Soybean is 
a leguminous plant, which produces soy protein, a renewable, inexpensive, and biodegradable 




Polysaccharidic polymers  
This class of biopolymers includes chitosan, alginate, hyaluronan and chondroitin 
sulphate, which are constituted by simple sugar monomers [38]. They can be obtained from 
different sources like microbes, animals, and plants. They share chemical similarities to heparin, 
show good hemocompatibility, are non-toxic, and have low costs in comparison with other 
biopolymers like collagen [39, 40]. Chitin is a natural polysaccharide obtained from crustacean 
shells, inset cuticles or fungal cell walls. Chitosan is the fully or partially deacetylated form of 
chitin and is used in a variety of applications like skin, bone, cartilage and vascular graft tissue 
engineering. They are biologically renewable, biocompatible, biodegradable, non-antigenic and 
bio functional biomaterials [41]. Owing to the wound healing properties of chitosan, bandages 
containing chitosan are commercially available as HemCon® bandages (HemCon Medical 
Technologies, Portland, OR).   Kweon et al., has proved that a water-soluble chitosan/heparin 
complex can be an effective wound healing accelerator [42] and Mayol et al. reported that a 
sterile and biocompatible chitosan gel increased proliferation of human foreskin fetal fibroblasts 
at 24h and accelerated wound healing in an in vivo model of pressure ulcers [43].  In a mice 
model Burkatovskaya et al., stably infected the open excision wounds with Pseudomonas and 
Staphylococcus bacterial and compared the antimicrobial activity by treating the wound with 
HemCom™ bandage and a chitosan acetate bandage with alginate sponge bandage and silver 
sulfadiazine cream. They demonstrated that chitosan acetate rapidly kills bacterial in the wound 
before systemic invasion and are superior to alginate bandages and silver sulfadiazine. 
Burkatovskaya et al. also showed that chitosan acetate bandages could effectively control the 
growth of bacteria in burns and prevent systemic sepsis [44-46].  Ong et al. demonstrated that 
refining chitosan dressings with polyphosphate and silver improves the hemostatic and 
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antimicrobial effects by accelerating blood clotting, increasing platelet adhesion and thrombin 
generation. They also show that testing this dressing in suitable animal models significantly 
reduced mortality from 90% to 14.5% in P.aeruginosa wound infection [47]. Cakmak et al. 
showed that meshes coated with triclosan loaded chitosan gels could be effective for preventing 
graft infections [48]. Although chitosan gels and bandages are shown to improve wound healing, 
they have been reported to cause lethal pneumonia in dogs and intra-tumor injection of chitosan 
to mice bearing tumors increases the rate of tumor metastasis and growth [49].  
Hyaluronan is a naturally occurring glycosaminoglycan and a major macromolecular 
component of the intracellular matrix of connective tissues such as vitreous of the human eye, 
umbilical cord, cartilage and synovial fluid. Hyaluronan has many physiological roles including 
tissue and matrix water regulation, structural and space-filling properties, lubrication etc. [50]. 
Pianigiani et al. developed a three-dimensional model based on fragments of human de-
epidermized dermis to study micro-perforated, hyaluronan-based membrane as a carrier of 
cultured epidermal cells and demonstrated that human epidermal cultures migrated from the 
hyaluronan membrane with growth resembling “in vivo” re-epithelialization [51]. Mineda et al. 
showed that the injection of 3D cultured mesenchymal stem cells in a non-cross linked 
hyaluronic acid gel on an ischemia-reperfusion injury to the fat pad in SCID mice promoted 
angiogenesis and tissue regeneration, thus proving a potential application of hyaluronan for 
wound healing [52].   
Chondroitin sulfate is another glycosaminoglycan found in the lubricating fluid of joints 
and is a component of cartilage, synovial fluid, and bone and heart valves. Chondroitin sulfate is 
a component of the dermal layer of FDA-approved skin substitute for treating burns [53] and a 
constituent of Integra® bilayered dermal regeneration template (Integralife, Plainsboro, NJ). It is 
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composed of collagen and chondroitin-6-sulfate for skin replacement by acting as a scaffold for 
dermal regeneration.  
Engineered Grafts  
There are also new biomaterials developed from the combination of several polymers 
such as, a novel three dimensional multilayered fibrous constructs developed from chitosan and 
hyaluronic acid on Poly (ε-caprolactone (PCL) by Reis et al. for application as wound dressing 
materials [54]. Wang et al. developed a biomimetic bi-layered gelatin-chondroitin 6 sulfate-
hyaluronic acid biopolymer with keratinocytes in the upper layer and dermal fibroblasts in the 
lower layer, resembling autologous skin equivalents [55].  
Tissue engineered autologous dermoepidermal skin grafts such as Permaderm (Regenicin 
Inc., New Jersey), denovoSkin and denovoDerm (University of Children’s Hospital, Zurich) and 
Epidermal autografts like Epicel (Genzyme Corp., New Jersey), MySkin (Altrika Ltd., New 
Jersey) and dermal epidermal autografts such as Hylograft 3D + Laserskin (Fidia Farmceutici, 
Abano Terme, Italy) have been recognized as promising alternatives to autografts [56]. These 
grafts use autologous fibroblasts and keratinocytes on a variety of scaffold materials like 
collagen-glycosaminoglycan substrate, collagen type I hydrogel or hyaluronic acid sheets and 
have the ability to close wounds by preventing dehydration and infections alongside avoiding 
any tissue availability concerns [56, 57].  
Although a new epidermis and dermis are formed during the repair and healing process, 
epidermal appendages such as hair follicles and sebaceous glands cannot be regenerated in these 
kinds of wounds [58]. The lack of hair in grafted sites has psychosocial, psycho-emotional and 
physiological impacts on the patient [59]. The loss of hair in cases like telogen effluvium and 
androgenetic alopecia is known to be associated with anxiety and distress with patient suffering 
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comparable to a severe chronic or life-threatening disease [59-61]. Since hair follicles are 
developed only during embryonic development and no new hair follicle formation occurs in the 
adult, and they cannot regenerate on their own after damage without a proper stimulus, new and 
healthy hair follicles or trichogenic cells need to be introduced to the affected area for 
regeneration of hair [62]. Hair cycling also serves as a self-protecting system, removing rapidly 
proliferating keratinocytes in the catagen and preventing oxidative stress and malignant 
degeneration [63]. Hair follicles may also have paracrine and endocrine function on various cells 
and structures within the skin. The factors secreted by follicles are also involved in wound 
healing, re-epithelialization and tissue expansion [64, 65].  
Hair Regeneration 
Hair follicles are highly regenerative, complex, ectodermal-mesodermal structures 
enriched with stem cells [62]. They consist of dermal papilla or follicular papilla, which 
determines the thickness, length and life cycle of hair. The hair bulb surrounds the dermal papilla 
and produces melanin granules along with hosting keratinocytes that are important for growth 
and regeneration of hair follicle and epidermis. The interactions between dermal papilla cells 
(mesenchymal) and follicular keratinocytes (epithelial) play an essential role in normal hair 
growth [66].  
Hair Follicle Formation 
Hair follicle is a complex organ formed during the first trimester of pregnancy. During 
embryonic development, after gastrulation, a single layer of pluripotent ectoderm covers the 
embryo surface. Following this, mesenchymal cells populate the skin and form the epidermis and 
its appendages. The basement membrane separates the skin epithelium from its underlying 
dermal mesenchyme.  The dermal cue signals the overlying epithelium to thicken and form a 
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placode that grows downward to form hair germ while, the epithelial cells cue the underlying 
mesenchyme to organize the dermal papilla (DP) (Figure 2). The interactions between hair germ 
epithelium and dermal papilla stimulate the epithelium to proliferate and produce hair follicle. As 
the follicle grows downward, the developing hair germ cells that lose contact with dermal papilla 
become the outer root sheath (ORS), while the cells that maintain contact become matrix cells 
that form the inner root sheath (IRS). Sebaceous glands emerge on the upper segment as 
appendages, which secrete lipids (sebum) into the hair canal at the skin surface.  
 As the hair follicles fully mature, the matrix cells at the base of the follicle proliferate and 
differentiate to yield a period of active hair growth (anagen). Due to the limited proliferative 
ability of the matrix cells, a destructive phase (catagen) is initiated which leads to apoptotic cell 
death of the lower two-thirds of hair follicle followed by bulge formation, and a resting phase 
(telogen). Postnatally, the resting phase is followed by a spontaneous mesenchymal –epithelial 
cross talk that leads to a new hair cycle initiation.  
Molecular Mechanisms Involved In Hair Follicle Formation and Regeneration  
The signaling communication between epidermis and the underlying mesenchyme 
initiates hair follicle morphogenesis. These interactions depend on the signaling interplay of 
secreted molecules of Wnt/wingless family, the hedgehog family, members of TGF- β /BMP 
(Transforming growth factor- β/ bone morphogenetic protein), FGF (Fibroblast growth factor) 
and TNF (Tumor necrosis factor) families [67-69]. Different combinations of these signals may 
dictate the outcome – tooth, scale, hair or feather formation [67-69]. The Wnt pathway plays an 
essential role during hair follicle induction, Shh (Sonic hedgehog) is involved in late stage 
differentiation and morphogenesis, Notch signaling determines stem cell fate and BMP is 
involved in cellular differentiation. Wnt signaling proceeds through EDA/EDAR/NF-κB 
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(Ectodermal dysplasia/receptor/ nuclear factor-kappa beta) signaling where NF- κB regulates the 
Wnt pathway and acts as a signal mediator by up regulating Shh ligand expression. Dermal Shh 
and PDGF (Platelet derived growth factor) signaling up-regulates dermal noggin expression, 
which counteracts BMP mediated β-catenin inhibition [70].  
Hair follicle induction 
In mice Wnt and BMP are essential for development of skin epithelium (from ectoderm), 
whereas, Wnt/β-catenin signaling alone decides dermal fate. Mesenchymal cells from diverse 
origins populate the dermis and start interacting with overlying epidermis to induce the growth of 
regularly interspaced hair placodes.  Specific cues from dermis are thought to induce overlying 
epidermal keratinocytes to assume an upright position and start proliferating.  The hair follicle 
hosts two stem cell populations – one in the bulge and the other in hair germ, and their growth is 
governed by the epithelial mesenchymal interactions [71-73]. Canonical Wnt/ β-catenin 
signaling acts as the primary switch for hair follicle fate as absence of β-catenin or the inhibition 
of β-catenin by ectopic epithelial expression of the secreted Wnt inhibitor Dkk1 results in the 
absence of hair follicle induction [74, 75]. Conversely forced expression of a stable form of β-
catenin causes strong enhanced placode formation due to the epidermal keratinocytes globally 
adopting a hair follicle fate [76, 77]. Edar signaling has also been implicated in hair follicle 
induction, by inhibiting BMP and refining β-catenin signaling by promoting Shh signaling[78].  
Wnt signaling is mediated by the stabilization and translocation of the key signal 
transducer β-catenin, which is known to be necessary for hair follicle formation and 
regeneration. Inactive β-catenin is degraded in the cytoplasm by the GSK3 kinases that causes 
phosphorylation of β-catenin’s N terminus and targets its cytoplasmic pool for ubiquitin-
mediated degradation [79, 80]. Activation by Wnt/Wingless inhibits GSK 3 kinases, thus leading 
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to β-catenin accumulation in the cytoplasm further translocating to the nucleus where β-catenin 
interacts with Lef-1/Tcfs to generate a functional transcription factor complex thereby, activating 
the downstream target genes [81, 82]. Expression of activated β-catenin throughout the basal 
epidermis induces de novo hair follicle formation within the epidermis [83, 84]. Hair follicle 
initiation also requires down regulation of keratinocyte growth factor (KGF) and epidermal 
growth factor (EGF) signaling. 
Hair follicle morphogenesis and organogenesis 
Epithelial placode cells signal the underlying mesenchyme to form the dermal condensate 
that gives rise to the dermal papilla. Shh plays a pivotal role in dermal papilla maturation and 
growth [85, 86]. The dermal condensate then signals the epidermis to allow placode growth into 
the underlying mesenchyme and thus reciprocal epithelial-mesenchymal signaling leads to the 
maturation and formation of different hair follicle lineages [87]. Local gradient of hair follicle 
activators and inhibitors determines epidermal keratinocyte and follicular keratinocyte fate.  
 BMPs are secreted signaling molecules of the TGF-β superfamily that exert a biological 
activity via interaction with specific BMP receptors. Interactions of exogenous BMPs with its 
receptor BMPRIA, phosphorylates SMAD 1, 5 and 8, which function in complexes with SMAD 
4. BMPs interact with a variety of growth factors like Wnt, Shh, TGF- β, EGF, FGF and Notch 
to a control a variety of cellular functions like cell proliferation, differentiation, apoptosis during 
skin and its appendage development [88-91]. The mesenchyme expresses Noggin, an 
extracellular BMP antagonist that induces hair follicle morphogenesis in the embryo and 
promotes new hair follicle growth postnatally [92, 93].  After the embryonic hair follicles have 
been initiated, BMP4 is expressed suggesting a negative feedback loop to prevent further new 
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hair follicle formation, but help with differentiation of cells into Inner root sheath (IRS) and hair 
shaft [94].  
 Shh signaling in skin controls the growth and morphogenesis of hair follicle epithelium 
through the Gli transcription factors [95]. It is crucial for hair follicle development and cycling as 
the deregulated members of Shh signaling cascade alter hair follicle formation and generates 
epidermal neoplasia [96]. Shh signaling controls the hair follicle morphogenesis and the 
initiation of primary and secondary hair follicles [86, 97].  In anagen skin, Shh is expressed in 
high levels in follicle matrix and acts as a mitogen to drive anagen regeneration [85, 98]. TGF-β2 
signaling is essential for transient induction of transcription factor Snail and activation of MAPK 
pathway which in turn regulates cell proliferation and cell adhesion, precisely governing 
epithelial proliferation, junctional remodeling and bud formation which helps in proper 
progression of hair morphogenesis [99].  
Hair follicle regeneration 
The hair cycle undergoes three phases, which includes growth phase (anagen), regression 
phase (catagen) and telogen [71, 100]. During regeneration, hair germ stem cells are activated 
followed by the bulge stem cells [71]. In anagen, the dermal papilla limits the newly formed hair 
bulb and stimulates the undifferentiated bulge cell progeny, which are present along the outer 
root sheath (ORS) to proliferate. This leads to the formation of transiently amplified matrix cells 
in contact with dermal papilla to terminally differentiate to form hair and inner root sheath.  
During anagen to catagen transition, matrix cells undergo apoptosis and dermal papilla retracts 
upward.  The result of growth factor signaling depends upon the cell type, the signal received 
and the receptor because, EGF and EGFR promote catagen, while IGF-1, FGF and PDGF 
promotes anagen. At the onset of telogen, BMP signals from surrounding dermal tissue impose a 
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threshold that needs to be overcome to initiate the next hair cycle or the dermal papilla is 
dislodged from the niche to maintain quiescence [92, 101-103]. TGF-β2 is an important factor 
for regeneration of hair follicle as it activates Smad2/3 pathway, which activates the target gene 
Tmeff1 that lowers the threshold of BMP in the niche promoting stem cell transition from 
telogen to anagen [104] .  
Engineering hair follicles in vitro  
Reynolds and Jahoda et al. demonstrated that dermal stem cells and dermal papilla cell 
isolation and expansion in vitro [73, 105, 106], which lead to revolutionizing concepts in 
engineering hair follicle in vitro and in vivo. The extraction of hair follicles require 
microdissection and enzymatic dissociation using collagenase, dispases or a combination of both, 
where enzymatic damage to isolated cells and cell surface proteins could be an issue. Also, 
freshly isolated dermal papilla cells retain a high tendency to aggregate, but this characteristic 
gradually disappears with extended culture. Horne et al. observed that dermal papilla cells 
cultured beyond 6 passages could not form cell aggregates or induce hair follicles, although 
supplementation with 10 ng/ml fibroblast growth factor 2 resulted in rescuing the lost inductive 
capacity [73]. To effectively engineer hair follicles in vitro, the replication of dermal papilla - 
epithelial cell interactions is essential. This has been achieved by combining different cell 
populations like dermal papilla cells, keratinocytes, follicle outer root sheath cells in collagen 
gels, matrigel or a sandwiched mixture of both [107, 108].  Epidermoid cyst like spheroids and 
spike-like structures has been formed by encapsulation of keratinocytes in hydrogel, 
keratinocytes or outer root sheath cells from human hair follicles in collagen gel or matrigel 
[109].  Wu et al. cultured dermal papilla cells and dermal sheath cells in a collagen gel and 
showed the formation of hair follicle like concentric structures [107]. In a model developed by 
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Havlickova, a pseudo dermis composed of collagen I was mixed with interfollicular dermal 
fibroblasts and topped with stacked layers of matrigel/dermal papilla cells and matrigel/outer 
root sheath keratinocytes or a single layer of mixed dermal papilla cells and outer toot sheath 
keratinocytes in the matrigel. In both the systems, outer root sheath keratinocytes formed 
spheroid aggregates and retained their characteristic keratin expression patterns, with mixed 
cultures resulting in better proliferation. Qiao et al. cultured a mixture of embryonic mouse 
follicular dermal and epidermal cells using a hanging – drop method in methylcellulose and 
demonstrated the formation of proto-hair confirming the necessity of mesenchymal-epidermal 
interactions in folliculogenesis [110] . 
In vivo induction of hair follicles  
In an approach by Yoo et al., dermal papilla-like tissue was developed from umbilical 
cord MSCs following exposure to a dermal papilla forming medium [111]. This papilla when 
transplanted into athymic mice produced new hair follicles. Cohen et al. showed the formation of 
new whiskers by implanting isolated rat and guniea pig vibrissa trichogenic papilla to the rat ear 
[112] while Oliver et al. attempted to regenerate partial or complete hair follicles and showed 
that root sheath cells could regenerate dermal papilla and that the regeneration of dermal papilla 
was a prerequisite for hair follicle formation [113]. Three major models have been developed to 
evaluate the regeneration of hair follicles in immunodeficient mice, namely the silicon chamber 
model [114], the patch implantation model [65] and the subcutaneous cell injection model [115]. 
In the silicon chamber model, a bell shaped silicon chamber covers the murine full-thickness 
wound and a mixture of neonatal mice epidermal and dermal cells could lead to hair formation 
after 3 weeks [114, 116]. Kishimoto and Ehama et al. assessed the trichogenic efficiency of 
dissociated dermal papilla cells and confirmed that only versican positive dermal papilla cells 
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could result in new hair follicle formation [117]. The subcutaneous injection model was 
convenient and rapid and used by Jahoda et al. to culture papilla cells and demonstrates hair 
growth after injection into follicles of a nude mice ear [73].  However, this model repaired the 
injured hair follicles but could not regenerate new follicles due to the absence of epidermal-
mesenchymal interactions. This model was also used by Zheng et al. to show that 
subcutaneously injecting a hair bud of epidermal cell aggregates and dermal papilla cells 
produced new hair, but the follicles grew outward from the aggregates and hair shaft projecting 
inwards into the aggregate [118]. Using this model, Wu et al. demonstrated that subcutaneous 
injection of mixture of dermal sheath cells and outer root sheath cells from human hair follicles 
within a customized cabin or as a cyst induced hair follicle-like structures indicating the need for 
cell aggregation [107]. Due to the associated limitations such as difficulties in controlling the 
injection location and cell confinement and guiding hair to grow outward, Jahoda et al. used the 
patch implantation model and demonstrated that both pelage and vibrissa dermal papilla cells 
retained their trichogenic capacity after introducing these cells between enzymatically separated 
epidermis and dermis of embryonic rat foot pads and then transplanting the combination into the 
rat dorsum [106, 119].  
Thus, to overcome the limitations associated with the current models, we have developed 
a novel three-dimensional model to aid with skin regeneration along with its associated hair 
follicle like structures. This model is composed of Wharton’s jelly mesenchymal stem cells 
cultured on a novel decellularized Wharton’s jelly matrix and supplied with appropriate cues to 




Ectodermal Differentiation of Wharton’s jellyMesenchymal Stem Cells for Tissue 
Engineering and Regenerative Medicine Applications 1 
Wharton’s jelly (WJ) is a mucoid, porous connective tissue that surrounds umbilical cord 
vessels and is derived from the extra embryonic mesoderm and partly from the embryonic 
mesoderm [120, 121]) (Figure 3). It protects umbilical cord vessels against damage from the 
compression of vessels and supports the cord in maintaining blood flow during fetal gasping, 
normal movements, and forces of labor [122, 123].  The extracellular matrix (ECM) components 
of WJ are also known to be associated with a large number of growth factors like the insulin 
growth factor, fibroblast growth factor (FGF), and transforming growth factor-b, which control 
cellular proliferation, differentiation, synthesis, and remodeling of the ECM [124-127]. This 
mucoid connective tissue hosts some mesenchymal stem cells (MSCs) immersed in a ground 
substance called Wharton’s jelly mesenchymal stem cells (WJMSCs) or umbilical cord MSCs 
[120, 121].  
WJMSCs isolation, optimization, characterization, and scale-up have been extensively 
studied and described by several researchers [128-130] and therefore only discussed briefly here. 
WJMSCs can be extracted from three relatively indistinct regions of WJ called the perivascular, 
intervascular, and subamniotic region [131]. Significant differences in vitro have been noted 
between MSCs isolated from these three different regions structurally, by 
immunohistochemistry, and functional analysis [132, 133]. WJMSCs are like fibroblasts or 








myofibroblasts [128, 129, 134] in appearance, are known to display MSC surface markers, and 
adhere to the plastic along with the capacity to self-renew and differentiate into various lineages 
like bone, cartilage, and adipose [128, 129]. A single donor can provide 4–5 X 109 cells in five to 
six passages [128]. Because they have a high ex vivo proliferation index and low population 
doubling times, they can undergo a 300-fold expansion within six to seven passages without 
developing an abnormal karyotype [128, 131, 132, 135, 136]. These cells also have the capacity 
to expand in a complete xeno-free and serum-free media along with exhibiting superior growth 
kinetics and functional angiogenesis [137]. WJMSCs are known to have higher colony forming 
unit-fibroblast (CFU-F)[138] and produce some cytokines like the granulocyte-macrophage 
colony stimulation factor and granulocyte colony stimulating factor [139]. WJMSCs can be 
cryopreserved in 90% fetal bovine serum (FBS), 10% dimethyl sulfoxide for future applications, 
with 80% cell viability after a freeze thaw cycle as demonstrated by Puranik et al. [129].  
The WJMSCs do not form teratomas, express a high percentage of tumor suppressor 
genes and secrete hematopoietic cytokines as compared to the other classes of MSC [140]. 
WJMSCs are also known to provide a stromal supportive niche for several primitive stem cell 
populations like hematopoietic stem cells and spermatogonial stem cells among others [141, 
142]. Saito et al. also demonstrated that WJMSCs can support the growth of embryonic stem 
cells [143].  
As described previously, MSCs obtained from WJ are multipotent and can successfully 
differentiate into diverse mature tissues favoring their use for regenerative medicine applications. 
WJMSCs share the same osteogenic differentiation pathway like the MSCs derived from bone 
marrow, but exhibit less mineralization in comparison to fetal bone marrow MSCs [144]. In 
comparison, WJMSCs also show higher collagen production and better compatibility with 
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decreased expression of collagen II. They also express prochondrogenic markers like Sox9 and 
Runx2 when co-cultured in the presence of microsphere-based scaffolds and polyglycolic acid 
scaffolds [145]. In addition, WJMSCs exhibit the potential to differentiate into cells of the 
adipogenic lineage as shown by the robust oil droplet formation when stained with oil O red 
staining following exposure to proper inductive stimuli and incubation times [132]. Due to their 
unique developmental position, these cells have an active growth potential, exhibit a specific 
phenotype, possess a fetal karyotype, express embryonic stem cell markers like Sox 2, Nanog, 
Oct 3/4A, MSC markers like CD73, CD90, CD105, and are also known to be hypoimmunogenic 
as they express molecules that can modulate natural killer cells and expand regulatory T-cell 
populations [146, 147].  
The ectoderm is one of the three primary germ layers that can differentiate into structures 
of various shapes and sizes like the nervous system (peripheral nerves, brain, and spine), which 
develops from the neuroectoderm, and surface ectoderm that develops into the epidermis (skin 
and skin appendages), the lining of the mouth, anus, and nostrils, and exocrine glands 
(mammary, salivary, sweat, and lacrimal glands)(Figure 4). The organogenesis of these organs 
and parts is initiated during the embryonic periods, while the morphogenesis continues 
postnatally. These organs also have limited ability for regeneration like the cyclical growth of 
hair and feathers, continuous growth of nails and the rodent incisor, and growth of the mammary 
gland during puberty and pregnancy [148]. Despite the diversity in form and function, all these 
organs originate from adjacent layers of the epithelial (ectodermal) and mesenchymal 
(mesodermal or neural crest derived tissues). The development of these organs begins with the 
local thickening of the epithelial layers to form an ectodermal placode and is followed by a 
condensation of mesenchymal cells under the placode, which then buds into or out of the 
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mesenchyme. Continued folding and branching of the epithelium follow growth of these 
epithelial and mesenchymal components, which result in the final shape and size of the organ. 
There has been a growing interest in studying the potential applications of WJMSC 
differentiation into cells of ectodermal origin.  
Surface Ectoderm-Related Regenerative Medicine Applications 
Skin is composed of epithelium and along with its associated underlying connective 
tissue plays a role as the primary defensive barrier to maintain the physiological homeostasis 
[149]. Numerous diseases associated with trauma, cancer, burns, and infections among others 
affect the normal architecture of skin. Keratinocytes form the major population of the epithelial 
layer, are tightly attached to each other by cell–cell junctions, and are arranged into a number of 
distinctive layers. The surgery site problems associated with autologous biopsies to collect 
keratinocytes and long keratinocyte doubling times in vitro necessitate the need for an effective 
alternative to these areas affected by diseases [150].  
Skin cells are continuously renewed by cells from the underlying epidermis, hair bulb, 
the melanocyte layer, and dermis [151]. Wound healing is characterized by complex biological 
and molecular events, which include inflammation, proliferation, and remodeling as described 
above [152, 153]. The major problems associated with prognosis of wound healing are scar 
formation, loss of normal function, and lack of formation of skin appendages, and the hurdles 
with healing and repair of wounds are ischemia to the affected areas, patient mobility, advanced 
age, and related diseases [154] .  
Currently, stem cell-based therapies are attractive candidates in regenerative medicine for 
treating skin injuries. For example, Arno et al. showed that wound healing of an excisional full-
thickness skin murine model was enhanced by WJMSC by promoting normal skin fibroblast 
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proliferation and migration [155]. In another example, Tam et al. used a nano scaffold of 
polycaprolactone with aloe vera as an antibacterial agent, impregnated with green, fluorescent 
protein-labeled WJMSCs in its conditioned medium, and studied healing of excisional and 
diabetic wounds in rats. Using scratch wound assays, they found that skin fibroblasts migrated 
faster from scratches into vacant areas accompanied by an increased expression of collagen I and 
III, elastin, fibronectin, superoxide dismutase, and metalloproteinase-1 compared to their 
controls [156]. These scaffolds with WJMSCs also showed rapid wound closure, re-
epithelization, increased number of sebaceous glands and hair follicles along with positive 
keratinocyte markers like cytokeratin, involucrin, filaggrin, and elevated expression of 
intercellular adhesion molecule-1 (ICAM-1), tissue inhibitor of metalloproteinase-1, and 
vascular endothelial growth factor-A when applied to excisional wounds in rats for 28 days 
[156].  
Zhang et al. studied the potential of a mixture of human umbilical cord MSCs, WJ pieces, 
and skin micro particles (composed of remnant tissue surrounding wounds made of cutaneous 
cells, transudate, inflammatory cytokines, inflammatory cell infiltration, fragments of hair 
follicles, sebaceous glands, sweat glands, and subcutaneous tissues) after transplantation into 10-
mm, full-thickness, mid-dorsal, excisional skin wounds in mice. The transplanted MSCs and the 
other components demonstrated the development of new born skin and its appendages along with 
newly generated layers of the epidermis, sebaceous glands, hair follicles, and sweat glands after 
7 days [134]. It is, therefore, possible that WJMSCs in combination with a three-dimensional 
(3D) scaffold mimicking the natural dermis and several paracrine and immunomodulatory 
factors could all act synergistically as wound dressings for slow healing and hard-to-heal chronic 
wounds [134, 156]. These experiments show that WJMSCs can be a novel cell source for human 
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oral mucosa and skin by forming epithelial keratinocytes [150]. However, these grafts have 
limited self-regeneration capacity and lack many skin appendages such as hair follicles, 
sebaceous glands, sweat glands and neural elements in the newly healed wounds [56, 157].   
Therefore, this dissertation describes a novel model using WJMSCs cultured on DWJM 
to assist in skin regeneration along with its associated hair follicle structures and sebaceous 
glans. DWJM is characterized and established as a 3D scaffold material for tissue engineering 
applications. WJMSCs and BMMSCs are cultured on this matrix and the biocompatibility and 
chemo-attraction capabilities are demonstrated. WJMSCs on DWJM in osteogenic differentiation 
media are shown to generate CK19 positive cells with hair like structures on DWJM. The 
underlying molecular mechanisms are studied here, along with the translatability of these 
structures to a suitable mice model to promote wound healing and complete skin regeneration 



































Figure 1-1 demonstrates the immediate response after a wound. (The inset micrograph - JNK 
signaling pathway, green immunofluorescence - phospho JNK); Figure 1-2 represents the 
inflammatory response, (inset micrograph – immunohistochemistry for macrophages on a mouse 
skin wound 3 days post-injury (F4/80, brown staining, methyl green counterstain)). Figure 1-3 
depicts the proliferation and migration of various cell types such as bulge cells and fibroblasts to 
the wound –edge epithelium (Inset micrograph is a mouse skin 5 days post injury representing 
thickened proliferative migratory repairing epithelium overlying fibrin clot and granulation tissue 
with angiogenesis (Red immunofluorescence is CK 14, while green immunofluorescence is 
CD31-endothelial cell marker)). Figure 1-4 shows the developing scar with altered matrix 
composition. (Inset – Masson’s trichrome stain of a developing scar of mice skin 14 days post 
surgery). 







Figure 2 – Molecular mechanisms and stages involved in hair regeneration  







Figure 3 – Native umbilical cord and Decellularized Wharton's jelly matrix 
Trichrome staining of human umbilical cord and decellularized Wharton’s jelly. Images A, B, D, 
E represent human umbilical cord, while images C and F show decellularized Wharton’s jelly 
matrix (DWJM) completely devoid of cells, but rich in collagen. Abbreviations – WJ – Wharton’ 
s jelly, UCA – Umbilical cord artery, UCV – Umbilical cord vein, UCB – Umbilical cord blood. 











Figure 4 - Ectodermal differentiation and development.  





Table 1 - WJMSCs as candidates for epithelial differentiation 
(Jadalannagari et al., Tissue engineering Part B, 21(3), 2015.)  
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Chapter 2: Decellularized Wharton’s Jelly from Human Umbilical Cord as a Novel 3D 
Scaffolding Material for Tissue Engineering Applications2  
Introduction 
Disease or trauma to the human body leads to damage and degeneration of tissues, 
thereby requiring their repair, replacement or regeneration. Tissue regeneration requires a 
combination of cells, scaffolds and appropriate media and growth factors. The properties of an 
ideal scaffold for tissue regeneration are high porosity, biocompatibility, biodegradability and 
suitable mechanical properties consistent with the location of implant [158]. Current treatment 
options for tissue regeneration involve the use of autografts or allografts. Nevertheless, 
autografts can be difficult to obtain due to expensive and painful procedures while allografts 
pose the risk of infections and immune rejections. Over the years, several types of scaffolds from 
natural or synthetic sources (polymers, ceramics, and composites) have been developed for 
regenerating tissues [158]. However, these scaffolds are associated with material specific 
limitations therefore creating interest in alternative biocompatible and bioactive natural or 
synthetic materials[159-165].  
Wharton’s jelly (WJ), a firm mucoid connective tissue that surrounds umbilical cord 
vessels [166],  has multiple unique biochemical characteristics that are desired in a scaffold. WJ 
is home to mesenchymal stem cells (MSCs) which are immersed in a ground substance that is 
rich in collagen and hyaluronan and contains numerous sulfated glycosaminoglycans [166]. 
MSCs widely express the archetypal hyaluronan receptor, CD44, which is also expressed on 
                                                
 
 
2 Under Review as Jadalannagari S, Converse G, McFall C, Buse E, Filla M, Villar MT,Artigues A, Mellot 
AJ,Wang J,Detamore MS,Hopkins RA, Aljitawi OA,  “Decellularized Wharton’s jelly from human umbilical cord 
as novel 3D scaffolding material for tissue engineering application “, PLOS ONE, 2016.  
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osteocytes, chondrocytes, and hematopoietic marrow cells [167] (Figure 4). WJ is also a rich 
source of peptide growth factors, notably insulin like growth factor-1 (IGF-1) and to a lesser 
extent platelet derived growth factor (PDGF), [127] which are both linked to controlling cell 
proliferation, differentiation, synthesis and remodeling of the extracellular matrix [168]. 
This work is predicated on the hypothesis that WJ could be effectively decellularized 
using customized procedures to produce a bioactive decellularized WJ matrix (DWJM). We also 
hypothesized that DWJM would provide a 3D environment well suited to specifically support 
undifferentiated mesenchymal cell culture. This paper examines in detail the decellularization 
processes used to obtain this matrix, its characterization along with the analysis of its contents. 
Here, we also show that WJ and BM (bone marrow) MSCs can be seeded on this matrix and 
cultured in vitro. Furthermore, we studied the gene expression profiles of these MSCs when 
seeded on our 3D scaffold and also assessed the biocompatibility of our matrix in vivo in a mice 




Materials and Methods 
Human umbilical cord collection, WJMSCs and WJ tissue harvest followed by 
decellularization were performed according to the IRB protocol # HSC 12129 of the university 
of Kansas Medical Center. Umbilical cords were immediately collected from consented donor 
mothers with full-term pregnancy after normal vaginal delivery. The umbilical cord was placed 
in a transport solution made of Lactated Ringer’s solution supplemented with penicillin 800 
U/ml (Sigma-Aldrich, St. Louis, MO), streptomycin 9.1 mg/ml (Sigma-Aldrich), and 
amphotericin 0.25 mg/ml (Sigma-Aldrich) and immediately refrigerated at 4°C. The 
decellularization process was initiated within 72 hours of umbilical cord collection.  
Decellularization process 
The decellularization procedure was recently described in our earlier publication [169]. 
Briefly, fresh human umbilical cords were transported from delivery room in a transport solution 
at 4°C. Umbilical cords were dissected in a laminar flow safety cabinet, by separating the matrix 
into large oval pieces from the surrounding membranes and vascular structures.  Following this, 
they were subjected to two cycles of osmotic shock, by alternating with a hypertonic salt solution 
containing sodium chloride, mannitol, magnesium chloride, and KCl with an osmolarity of 
approximately 1,275 mOsm/L and 0.005% Triton X-100 in ddH2O at 5,000 rpm in centrifuge at 
4° C.   
After two cycles of osmotic shock, the tissues were subjected to an anionic detergent 
(Sodium lauryl) and, sodium succinate (Sigma L5777), alternating with a recombinant nucleic 
acid enzyme, (Benzonase™) in buffered (Tris Hcl) water for 16 hours.  Following this, an 
organic solvent extraction with 40% ethyl alcohol was performed for 10 minutes at 5,000 rpm in 
the centrifuge at 4° C.  All of the detergent and other processing residuals were then removed 
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utilizing ion exchange beads (IWT-TMD (Sigma), XAD-16 Amberlite beads (Sigma), and 
Dowel Monosphere 550A UPW beads (Supelco)) in a reciprocating flow-through glass system 
for 30 hours at room temperature in ddH2O.  The decellularized matrix was cryopreserved using 
10% human recombinant albumin (Novozymes) and 10% DMSO (Sigma) solution in standard 
RPMI media, employing a material specific computer controlled freezing profile that was 
developed to freeze at -1°C/minute to -180°C[170]. 
Assessment of DWJM scaffold 
DNA Quantification.  
The DNA was isolated using DNeasy Blood and Tissue Kit from Qiagen (Duesseldorf, 
Germany) per manufacturer’s instructions.  Pico Green dye (Molecular Probes, Eugene, OR) was 
used and the extracted DNA was quantified fluorometrically using Quant-it dsDNA Kit HS from 
Invitrogen (Carlsbad, California). The amount of extractable DNA was calculated per wet weight 
of tissue and expressed as a percent reduction in extractable DNA relative to non- decellularized 
tissues. All analyses were run in triplicate.  
Glycosaminoglycans (GAGs) content analysis. 
The Blyscan assay (Bio color, UK) was used for analysis of sulfated glycosaminoglycans 
according to the manufacturer’s recommendations.   Tissue samples from native umbilical cord 
WJ and DWJM were analyzed and the results were reported in μg/mg of glycosaminoglycan per 
wet tissue weight.  
Hyaluronic acid immunohistochemistry. 
After deparaffinization DWJM samples were blocked in 3% hydrogen peroxide for 10 
minutes, rinsed and blocked in strepatividin/biotin (Vector Laboratories, Burlingame, CA.). The 
samples were rinsed and stained with hyaluronic acid binding protein (RMD Millipore, Danvers, 
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MA.) at 1:200 dilutions for 60 minutes at room temperature followed by a 15-minute incubation 
with LSAB+ strepatvidin-HRP (Dako, Carpinteria, CA).  DAB+ chromagen (DAkp, Carpinteria, 
CA) was applied for 5 minutes and slides were counterstained with hematoxylin.  
Protein estimation by mass spectrometry 
DWJM samples from two different umbilical cord samples were analyzed following two 
methods of protein extraction. For the first method DWJM was snap-frozen using liquid 
nitrogen, homogenized using tissue homogenizer, and suspended in WJMSC culture medium 
described below. In the other method Ready Prep Protein Extraction Kit (Bio-Rad Laboratories, 
Inc., Hercules, CA) with zwitterion detergent ASB-14 as a solubilizing agent was used. This step 
was followed by a cleanup step using Ready Prep 2-D Cleanup Kit (Bio-Rad Laboratories, Inc., 
Hercules, CA). The protein pool present in the extracts were denatured in 6M guanidine 
hydrochloride, reduced, alkylated, and subsequently digested for 18 h with sequencing grade 
trypsin (12 ng/L, Promega, Madison, WI) at 37°C. Following enzymatic digestion, the extracted 
peptides were concentrated on a centrivac concentrator (Labconco, Kansas city, MO) to a final 
volume of 50 µl. The peptide extracts were analyzed by reversed phase chromatography using 
2D NanoLC (Eksigent Technologies, Dublin, CA) coupled to a LTQ FT mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA). The mass spectrometer was controlled by the 
Xcalibur software to perform continuous mass scan on the FT in the range of 400-1900 m/z at 
50,000 resolutions, followed by MS/MS scans on the ion trap of the six most intense ions. All 
tandem ma scans were searched using Proteome Discoverer (version 5.3, Thermo Fisher) against 
a human protein database using trypsin cleavage specificity, with a maximum of 2 missed 
cleavages. The following variable modifications were selected: oxidation of M, deamidation of N 
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and Q and carboxymethylation of C was selected as a fixed modification, and a maximum of 4 
modifications/peptides were allowed. 
Mechanical testing 
DWJM tissue sample was placed on a glass slide and the diameter was measured with a 
micrometer under a stereomicroscope. Tissue specimen was then loaded in an RSA-III dynamic 
mechanical analyzer (TA Instruments, New Castle, DE) and tested under unconfined uniaxial 
compression rate of 0.005mm/s to generate the stress-strain curve. Matrix height was measured 
directly using the RSA-III. 
Isolation, expansion, and WJMSCs seeding onto DWJM 
Preparation of DWJM for WJMSC seeding. 
Freshly obtained fragments of DWJM were transferred to a large petri dish and covered 
with phosphate buffered saline (PBS). DWJM pieces (5-7mm in diameter) were obtained using a 
sterile 5-7 mm skin punch biopsy kit. The resulting DWJM pieces were cylindrical in shape with 
non-uniform heights, which varied between 2-3 mm. The volume of the obtained DWJM 
scaffolds’ was ~72 mm3. From this point on, these pieces of DWJM will be referred to as DWJM 
scaffolds. DWJM scaffolds were transferred using sterile forceps to a large petri dish and washed 
with PBS twice.  At the time of seeding, the DWJM scaffolds were transferred to non-tissue 
culture treated plates.     
MSC isolation and expansion 
a. WJMSCs - WJMSCs were isolated and expanded according to the procedures described by 
Wang et al. [171]. Briefly, the outer layer of the cord was carefully removed and the cord was 
cut into smaller segments. The blood vessels were dissected from these cord segments and then 
cut into smaller pieces and digested with Collagenases (Worthington Biochemical Corporation, 
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Lakewood, NJ) in low glucose DMEM (Sigma-Aldrich) with 10% FBS (Atlanta Biologics, 
Atlanta, GA) and 1% Penicillin/Streptomycin (Sigma-Aldrich) overnight at 37°C to obtain 
WJMSCs. The WJMSCs were passaged and maintained in low glucose DMEM with 10% FBS 
and 1% Penicillin/Streptomycin. WJMSCs from passages 4 - 9 were used for the experiments.  
b. BMMSCs - BMMSCs were isolated from bone marrow aspirates of healthy consented donors 
at University of Kansas Medical Center (HSC # 5929). The cells are isolated following standard 
ficoll density gradient separation method (Lymphoprep, Stem cell technologies, Vancouver, BC). 
The isolated cells were maintained in high glucose DMEM (Sigma-Aldrich), 20% FBS (Atlanta 
Biologics) and 1% Penicillin/Streptomycin (Sigma-Aldrich) at 37°C, 5% CO2 and 90% 
humidity.   
MSC characterization and phenotyping  
MACS Miltenyi Biotec MSC human phenotyping kit was used for the characterization of 
expanded WJMSCs and BMMSCs. Flow cytometry analysis was performed using BD Flow 
cytometer LSR2. MSCs isolated from human umbilical cord and bone marrows were stained for 
CD14, CD20, CD34, CD45, CD73, CD90 and CD105.  
MSC seeding onto DWJM  
 For each set of seeding experiments, single-donor (n=1) WJMSCs/BMMSCs was used. 1 
x 106 MSCs were suspended in 50 µl culture medium and seeded on each DWJM scaffold 
(average seeding density was 1.4X1044 x 104/mm3 DWJM scaffold) in a 48-well plate. 1 ml of 
medium/well was added to the cells on the scaffolds. For the gene expression studies, 0.25 x 106 
– 1 x 106 WJMSCs/BMMSCs of passage 4-9 were seeded on DWJM in a 24-well non tissue 





Evaluating seeded WJMSC adherence to and penetration of DWJM scaffolds 
a. Confocal microscopy - To assess WJMSCs attachment to DWJM scaffolds, 1 x 106 WJMSCs 
were seeded on each DWJM scaffold in a 24-well culture plate. After 2 hours of cell seeding 
and culture, these scaffolds were transferred to a viewing chamber for confocal microscopy 
examination using Fluoview scanning laser confocal microscope (Olympus, Center Valley, PA). 
Prior to viewing, seeded DWJM scaffolds were rinsed twice with PBS and incubated with 
culture medium containing 2 µg Calcein stain (Molecular Probes, Eugene, OR) added to each 
seeded DWJM scaffold. Calcein is a cell-permeant dye that is converted to green-fluorescent 
Calcein in live cells. Using this stain, we tracked live WJMSCs seeded onto DWJM scaffold for 
24 and 48 hours after cell seeding.  
b. Dual beam electron microscopy – MSCs were seeded on DWJM as described in 2.3.4 and 
cultured in their appropriate media for 7 days. The matrix with cells was collected after 24 hours 
and day 7 and was fixed overnight in 4% paraformaldehyde (VWR, Randor, PA) in PBS at 4°C. 
Tissue Specimens were washed three times in PBS. Following this, specimens were stained for 
24 hours with 2% Osmium Tetroxide (OT) to label lipids, as OT gives off a strong electron 
backscatter signal. OT stained samples were washed three times for 10 minutes in PBS. All 
samples were gradually dehydrated with ethanol and cleared in xylene, before being embedded 
in paraffin. Samples were sectioned to thicknesses of 10 µm or 20 µm using a microtome (Leica, 
Buffalo Grove, IL) and mounted on Super Frost glass slides (Thermo Fisher, Waltham, MA). 
OT-stained samples were deparaffinized in two washes of xylene for 3 minutes each. Further, 
OT samples were critical point dried in 100% ethanol using an Autosamdri 815B (Tousimis, 
Rockville, MD). Samples were sputter-coated with 5 nm of copper using a Q150T Turbo-
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Pumped Sputter Coater (Quorum Technologies, West Sussex, and United Kingdom). Samples 
were imaged using a Versa 3D Dual Beam electron microscope (FEI, Hillsboro, OR) at a 
voltage of 30 kV. The Everhart-Thornley detector (ETD) and circular backscatter (CBS) 
detectors were used to detect secondary electrons and backscatter electrons, respectively. 
c. Scanning electron microscopy (SEM) - DWJM scaffolds were fixed in 2 % glutaraldehyde 
for SEM processing. The fixed samples were washed with PBS for 10 minutes, placed into 
buffered 1% osmium tetroxide for 1 hour, and then washed 3 times 10 minutes each in distilled 
water. Further, the samples were dehydrated through a graded series of ethanol from 30%, 70%, 
80%, 95%, and 100% for 15 minutes each. Following this, the samples were critical point dried 
in CO2 in a model EMS 850 dryer, then they were mounted onto aluminum mounts and sputter 
coated with gold in a Pelco SC-6 sputter coater. Finally samples were viewed using a Hitachi S-
2700 scanning electron microscope. 
d. Transmission electron microscopy (TEM) - For TEM, scaffolds was rinsed in a buffer prior 
to fixing in 1% to 2% osmium tetroxide for 1 hour. After osmication, the scaffolds were 
dehydrated for 10-15 minutes in 30%, 70%, 80%, 95%, and 100% ethanol series before placing 
them in propylene oxide (PO) for 10 minutes twice. The scaffolds were then placed in equal mix 
of resin and PO overnight to allow tissue infiltration. At this point, the half/half mix was 
removed from the tissue and fresh 100% resin mixture was added to the sample and was allowed 
to sit on a platform rocker for at least 30 min. Subsequently, the samples were covered in resin. 
Finally, the samples were placed in 60°C oven overnight to cure the resin. Samples were then 
sectioned using a Leica UCT ultra microtome at 80 nm in thickness and contrasted with 4% 




e. Live cell Imaging –DWJM scaffolds of 30µ thickness were placed on the base of a 12 well 
plate and the matrix was blocked with 3% BSA for 2 hours and incubated with 3 µl anti-
fibronectin antibody [F1] (Alexa Fluor® 488) (Abcam, Cambridge, MA) at 4°C in dark for 12-
15 hours. WJMSCs of passage 4 - 5 were cultured in a 12 well plate and labeled with cellVue® 
burgundy labeling kit (Affymetrix eBioscience, Santa Clara, CA) as per the manufacturer’s 
instructions, immediately prior to seeding on the scaffolds. Briefly, 2.5 – 5 X 105 WJMSCs were 
seeded on the labeled matrix and cultured for 24 hours at 37°C and imaged using a Leica 10X 
HC PL Fluotar 506505 objective on a semi-automated Leica DMIRE2 inverted epifluorescent 
microscope outfitted with a Ludl Bioprecision motorized stage, Sutter Instruments Xenon 
Lamphouse with shutters and a Retiga SRV CCD camera controlled by custom TiLa KU (Time 
Lapse KU) acquisition and image processing software. Regions were imaged in Bright field, 
GFP (Chroma 41001 HQ480/40 excitation HQ535/50 Emission) and CY5 (Chroma 49006 
ET620/60 excitation, ET700/75 emission). DWJM with WJMSCs was imaged for 18 hours, at 
every 15-minute interval.  
f. Histology and Immunohistochemistry - DWJM scaffolds were fixed in either 10% formalin 
or 4% paraformaldehyde, embedded in paraffin, sectioned, and stained with H&E. Slides were 
reviewed using Olympus BX40 microscope and pictures were acquired using DP72 digital 
camera. 
Tissue specimens from animal study were decalcified in a routine matter (using Rapid 
bone decalcifier solution from American MasterTech for 5-10 minutes), paraffin embedded, 
sectioned vertically, and stained with H&E. GFP immunohistochemistry staining was done by 
incubating slides with rabbit monoclonal GFP primary antibody from CST in 1:100 dilution for 
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45 minutes, followed by mach 2 rabbit secondary antibody for 45 minutes using a Clinical 
intellipath FLX automated slide stainer. 
Evaluating seeded WJMSC proliferation  
To assess WJMSC’s viability and proliferative response following their seeding on 
DWJM, AlamarBlue® (AB) cell viability assay (ThermoFisher Scientific, Waltham, USA) was 
utilized. AB is a fluorometric assay that correlates with cell metabolic activity.  DWJM scaffold 
pieces (7 mm in diameter and 2-3 mm in height) were seeded with expanded human WJMSCs. 1 
x 106 cells were seeded on each DWJM scaffold. For controls, WJMSCs 1 x 106 were cultured 
as a monolayer in each well of a 24-well plate. AB was assessed 24 and 48 hours as well as 1 
week following WJMSC seeding.  These experiments were done in triplicate.   
Evaluating WJMSC migration toward DWJM using migration Assays 
3 - 7 x 105 WJMSCs   were loaded to the upper chamber of Trans well set (Costar, 
Corning Inc.) and minced DWJM tissue was added to the lower chamber in low glucose DMEM 
with 10% FBS and 1% Penicillin/Streptomycin. After 4 hours, Trans-wells were removed and 
the migrated cells were counted using a Vi-cell (Beckman-Coulter). All the experiments were 
conducted in triplicate.  
Molecular studies 
RNA extraction from cells 
WJMSCs and BMMSCs were cultured as a monolayer (2D) or on DWJM (3D) as 
described above for 7 days. The cells were collected at day 0 (monolayer prior seeding DWJM), 
day 4 and day 7 after seeding onto the matrix. WJMSCs were harvested from the scaffolds 
following overnight digestion with Collagenase II. The MSCs were washed twice with PBS and 
centrifuged at 13000 rpm, 4°C for 20 minutes to obtain a cell pellet. The cell pellet was 
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suspended in 1 ml of Trizol (Life technologies) and stored at -80°C until further processing. 
Once all the samples were collected, RNA was extracted using the standard procedure as 
described by the manufacturer (Life technologies, Carlsbad, CA). Briefly, aqueous phase 
containing RNA was separated using 0.2 ml chloroform, 0.7 volumes of isopropanol was added 
and centrifuged to precipitate RNA. The RNA pellet was washed twice with 75% ethanol and 
dissolved in 30-50µl of nuclease free water. RNA was quantified using Nano drop 
spectrophotometer 8000. 1.5µg of RNA was treated with DNA-freeTM DNase treatment and 
removal kit (Life Technologies).  High capacity cDNA reverse transcription kit (Applied 
Biosystems) was used to generate cDNA from the extracted total RNA samples using Bio-Rad 
T100 thermal cycler. 
Quantitative real-time PCR analysis 
The quantitative real-time PCR (qPCR) reactions (20 µl) were performed with TaqMan 
gene expression master mix (Life Technologies), and TaqMan array 96 well plates (Applied 
Biosystems, Foster City, CA) using StepOnePlusTM real-time PCR system (Applied Biosystems). 
The primers used are described in Table 2. The qPCR reactions were performed in triplicate. 
StepOnePlusTM real-time PCR system (Applied Biosystems) was used for the qPCR. GAPDH 
was used as an internal control to normalize the samples to obtain ∆Ct. 2-∆∆Ct was used to analyze 
the relative gene expression levels.  
Animal studies  
  DWJM scaffolds were washed twice in PBS and pre-incubated in low glucose DMEM 
(Sigma-Aldrich) with 10% FBS (Atlanta Biologics) and 1% Penicillin/streptomycin (Sigma-
Aldrich) for 24 hours at 37°C, 5% CO2 and 90% relative humidity. After incubation, the 
scaffolds were washed multiple times in PBS to remove the media before transplantation in the 
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mice.  All the animal experiments were performed according to the University of Kansas 
Medical Center IACUC protocol # 2013.2158. All the animal studies were performed on 
transgenic 10kB DMP1 - Cre floxed mice (6-8 week old) expressing osteocyte specific green 
fluorescent protein (GFP)[172]. Mice were anesthetized with intraperitoneal injection (IP) of 
ketamine (90-150 mg/kg) (Vedco) and xylazine (7.5-16 mg/kg). Buprenorphine SR (0.15-0.5 
mg/kg) (Zoopharm pharmacy) was given intraperitoneally pre-op. One midline skin incision of 
approximately 1cm in length was made on the dorsal surface of the cranium, followed by the 
separation of skin and periosteum. A 5 mm cranial defect was made with a trephine bur (Fine 
Science Tools, Foster City, CA) attached to an electric Dremell hand piece (Ideal micro drill, 
Harvard apparatus, Holliston, MA). A full-thickness parietal bone defect was created with 
minimal invasion of the dura matter. The defect was left empty (n = 4) or filled with the 
decellularized matrix (n = 4) and the skin was sutured with 5-0 coated Vicryl (polygalactin 910) 
(Ethicon™, Johnson and Johnson Co., New Brunswick, NJ). Animals that had cranial defects, 
but received no implant served as sham-operated controls.  Craniotomy defects in mice were 
either left unfilled (control) or filled with DWJM to study the cellular migration and localization 
by observing GFP expression.  
IVIS Imaging  
The mice were imaged using IVIS imaging station (PerkinEmler) 24 and 48 hours post-
surgery. Mice were anaesthetized with isofluorane gas prior to imaging. The animals were 
euthanized after imaging according to the protocol and cranial samples with the matrix were 




All data were expressed as means ± standard error of mean (SEM) and analyzed using, 
student’s t-test, two-way analysis of variance (ANOVA) with Bonferroni post-test, or Man-
Whitney U test. A threshold of p ≤ 0.05 determined statistical significance. The statistical 






Characterization of DWJM Scaffolds  
 The isolated DWJM scaffolds (Figure 5A) were tested for the success of decellularization 
process. Histologically, the decellularized Wharton’s jelly matrix was porous and devoid of any 
intact cells, nuclei or other cellular components (Figure 5B).  The DWJM matrix was also found 
to have abundant hyaluronan glycosaminoglycan as observed in the immunohistochemistry 
images (Figure 5C). Scanning electron microscopy pictures indicated that DWJM had open 
spaces resembling lacunae, with sizes ranging from 20-100 µm (Figure 5D). Transmission 
electron microscopy also demonstrated absence of intact cells in the examined DWJM scaffold 
(Figure 5E).   
DWJM scaffold biochemical and biomechanical characteristics 
DNA quantification studies  
 DNA was isolated from the native WJ matrix and from DWJM and quantified as described 
above. The amount of mean dsDNA content per DWJM sample wet weight was 1.7 x 10-3 µg/mg 
(range: 1.4 x 10-3 – 2 x 10-3 µg/mg) with standard deviation of 0.2 x 10-3 µg/mg while the mean 
dsDNA per WJ matrix wet weight sample was 5.1 x 10-2µg/mg (range: 3.17 x 10-2 – 7.33 x 10-2 
µg/mg) with standard deviation of 1.9 x 10-2 µg/mg (Figure 6A).  Therefore, for all the analyzed 
scaffolds, 96.6% ± 0.4% of dsDNA was removed. 
Protein content analysis 
Mass spectrometry revealed that examined DWJM matrix pieces were composed of 
several structural proteins, including collagen I, III, VI, and XII. Transforming growth factor 
beta was also observed, in addition to matrix proteins like fibronectin-I (binds to extracellular 
matrix components such as collagen, heparin sulfate), tenascin and lumican. A full list of the 
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proteins identified on mass spectrometry evaluation of DWJM, prepared by both methods, as 
shown in Table 3. 
 Glycosaminoglycan content analysis  
 GAGs are glycoproteins with a protein core and polysaccharide branches with carboxylic and or 
sulfate ester groups and that form bridges and link collagens to construct an interpenetrating 
network of extracellular matrix to maintain and define shape of connective tissues and organs 
[173, 174]. Glycosaminoglycan analysis indicated that DWJM contained sulfated GAGs (mean = 
0.661 ± 0.107 μg/mg), which was significantly less than the native umbilical cord Wharton’s 
jelly tissue (3.0 ± 0.355 ug/mg, <p = 0.05) (Figure 6B).  
Mechanical testing 
   After decellularization, the DWJM matrix under unconfined uniaxial compression 
demonstrated a curve characteristic of elastomeric scaffolds (Figure 6C), thus indicating DWJM 
as a suitable scaffolding biomaterial [175].  
DWJM scaffold seeding with WJ and BM MSCs    
MSC characterization by flow cytometry  
The isolated WJMSCs (Figure 7A) and BMMSCs (Figure 7B) were plastic adherent and stained 
positive for MSC markers such as CD 73, CD 90, and CD 105 by flow cytometry. WJ and BM 
MSCs were negative for hematopoietic cells markers like CD45, CD34, CD14 or CD11b, 
CD79α or CD19. 
Assessment of MSC adherence to and penetration of DWJM 
 A green Calcein AM stain was used to study WJMSC seeded onto DWJM scaffolds.  Within 2 
hours of seeding, clusters of round cells were observed on the surface of DWJM scaffolds 
(Figure 8A-B). Histological examination of the DWJM matrix after seeding WJMSCs for 6 
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weeks also showed the presence of elongated and spindle shaped cells covering the outer surface 
of the matrix (Figure 8C).  Similar observations were made when the matrix with WJMSCs was 
observed under a scanning electron microscope, which also revealed the presence of spindle 
shaped and round cells (Figure 8D). Thus, WJMSCs cultured on DWJM adhere to the matrix but 
acquire different cellular morphologies.  
 Dual beam imaging - WJMSCs and BMMSCs were seeded onto separate DWJM scaffolds and 
cultured for 7 days in appropriate media. Samples were collected at 0, 1 and 7 days after seeding 
the scaffolds and imaged using a FEI Versa 3D dual beam microscope. DWJM was composed of 
fibers of varying thickness (Figure 9A*) while in DWJM seeded with cells; several clusters of 
circular lipid structures were identified (Figure 9B*- E*).  WJMSCs were positively identified 1 
mm medially from the outer edge of DWJM at day 1 and day 7 (Figure 9G#, H# respectively), 
whereas, BMMSCs were identified approximately 800 µm from the outer edge at day 1 (Figure 
9I#) and 1 mm medially from the outer edge at day 7 (Figure 9J#). Thus, these images 
demonstrate that WJMSCs and BMMSCs not only attached on the surface, but also penetrated 
into the matrix.  
Live cell Imaging – DWJM is composed of fibronectin, which was labeled using alexaflour 488-
conjugated anti-fibronectin antibody. This staining revealed fibrous network of fibronectin 
within DWJM (Figure 10). WJMSCs labeled in burgundy color were visualized on the surface of 
DWJM, inside the matrix and outside the matrix.  Time-lapse imaging over 18 hours 
demonstrated migration of WJMSCs in and out of DWJM. In addition, WJMSCs successfully 
populated DWJM matrix (Figure 10 and videos 1-2). 
Proliferation of WJMSCs seeded onto DWJM scaffolds  
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Alamar blue cell viability assay was performed to assess the proliferation of WJMSCs 
seeded onto DWJM. For these experiments, WJMSCs were cultured as a monolayer (2D) or 
seeded over DWJM scaffolds (3D). The viability of the cells was calculated as fluorescence 
readout in the assay. Increased fluorescence reading directly correlates to proliferation and 
viability of the cells. After 1 week WJMSCs cultured in 3D had lower fluorescence compared to 
WJMSCs cultured in 2D, indicating that the cell-matrix interactions allowed the cells to 
proliferate but not as much as WJMSCs cultured in 2D (Figure 11A).  
Cell migration Assay  
 In 4 hours, a significantly higher number of WJMSCs migrated across the Trans well 
when DWJM was present (Figure 11B) potentially indicating that DWJM matrix acts as a chemo 
attractant.  This chemo attractant quality of the matrix was further investigated in our animal 
model. 
Gene expression studies  
A) Cell adhesion genes (Figure 12A, Figure 13A) – Expression levels of cell adhesion genes CD 
44, Endoglin (CD105), ITGB1 (CD29), Thy1 (CD90), ALCAM (CD166) and VCAM1 were 
tested in WJMSCs and BMMSCs after culturing in DWJM for 7 days. There was no significant 
change in the expression of ITGB1, while ENG, THY1, ALCAM and VCAM1 remained below 
baseline levels in WJMSCS cultured in DWJM. On the other hand, after 4 days, BMMSCs 
cultured in DWJM showed 0.5 fold reductions in the expression of ENG, ITGB1, THY1, 
ALCAM and VCAM1 genes. However, by day 7 we observed an increase in expression of these 




B) Chondrogenic genes (Figure 12B, Figure 13B) – The expression of prechondrocyte marker 
SOX9 and chondrocyte markers aggrecan (ACAN) and COL2A1 were examined in WJMSCs 
and BMMSCs cultured in DWJM. ACAN and COL2A1 were undetected in WJMSCs cultured in 
DWJM, while in BMMSCs; ACAN was down regulated over time. SOX9 expression was up 
regulated in WJMSCs and BMMSCs compared to baseline with BMMSCs showing 4-fold 
increase at day 4 and 15 fold increase at day 7. HAS2 expression was increased 3 fold at day 4 
and 1 fold at day 7 for WJMSCs cultured in DWJM, while BMMSCs showed a decrease in 
HAS2 expression.  
C) Adipogenic genes (Figure 12C, Figure 13C) – WJMSCs and BMMSCs demonstrated 
expression of the adipogenic differentiation genes - fatty acid binding protein (FABP4) and 
Peroxisome proliferator- activation receptor – γ (PPARγ). WJMSCs cultured in DWJM 
demonstrated a decrease in the expression of FABP4 and PPARγ, while BMMSCs demonstrated 
increased expression of both genes at one week compared to baseline. Though these differences 
were statistically significant, their biological significance is unclear given the magnitude of 
change is small in both cases.  
D) Myogenic genes (Figure 12D, Figure 13D) - The expression of vimentin (VIM), byglycan 
(BGN), desmin (DES), actin alpha 2 (ACTA 2) and collagenase 6 (COL6A1) were studied in 
WJMSCs and BMMSCs cultured DWJM. At day 7 of culture, DES was down regulated in 
WJMSCs, while BMMSCs demonstrated no significant change from baseline. However, the 
decrease in ACTA2 expression in both the cell lines was noteworthy.  




Figure 13E) – The expression of RUNX2, a key transcription factor associated with osteoblastic 
differentiation was evaluated in WJMSCs and BMMSCs cultured in DWJM. In WJMSCs the 
expression of RUNX2 was increased 4 folds above baseline value at day 4 followed by 
significant decrease at day 7. However, in case of BMMSCs expression of RUNX2 increased by 
0.5 fold and 1.5 fold over baseline values, at day 4 and 7, respectively. The expression of other 
osteogenic lineage markers Alkaline Phosphatases (ALPL) and COL1A1 was assessed over time 
and it was observed that COL1A1 was down regulated in both cell types, while there was no 
significant difference in ALPL levels in BMMSCs. WJMSCs exhibited transient increase in 
SPP1 expression (8 fold increase) at day 4, while WJMSCs and BMMSCs demonstrated no 
significant change in SPP1 expression at day 7 compared to baseline.  
F) Apoptosis, Proliferation, and other differentiation genes (Figure 12F, Figure 13F) – 
WJMSCs and BMMSCs cultured in DWJM showed no significant change in the expression of 
BAX (apoptotic regulator) at day 7, while proliferation marker (MKI67) exhibited significant 
decrease in gene expression when compared to the respective baseline values. WJMSCs 
demonstrated a significant, albeit small, decrease in the expression of PCNA at week 7.  
Animal studies  
Mice that had the 5 mm defect alone (Figure 14A) served as our control group, while the 
animals that received DWJM were the treatment group (Figure 14B). All the animals survived 
surgeries and were imaged under anesthesia at 24 hours and 2 weeks post surgery (Figure 14D) 
and were euthanized as per the protocol. Structural integrity of DWJM was evaluated by visual 
inspection after removing the skin and exposing the defect at the end of the experiment (Figure 
14C). The matrix appeared intact 14 days after surgery (Figure 14C) and histological 
examination revealed the presence of cells (Figure 14E, H, I), some of which were also GFP 
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positive (Figure 14F, J). The cells migrated into the matrix as early as 24 hours thereby 





This chapter demonstrates that DWJM is a novel 3D scaffold that is biocompatible and 
allows cellular penetration and has suitable mechanical properties for cellular growth and 
proliferation. Although a wide variety of scaffolds – synthetic and natural are already available 
for tissue engineering, natural polymers like collagen, gelatin, silk, chitosan, and elastin pose 
some difficulties with processing, purity and protein denaturation, while, metal alloys and 
osteoconductive ceramics are difficult to handle and shape and also lack biodegradability [159, 
160, 176]. Though polymers like poly (lactic-acid) (PLLA), poly (glycolic acid) (PGA), 
polycaprolactone (PCL), poly (lactic acid-co-glycolic acid) (PLGA) fit the properties of an ideal 
scaffold, they are synthetic in origin and lack biological properties, thus, arising the 
necessity/need for developing an ideal natural scaffold material [159-164, 177].  
In the current study, we establish DWJM as a novel 3D matrix, completely devoid of 
cells and dsDNA.  In contrast to the methods published by Chan et al. [178] , we demonstrate a 
method to decellularize the WJ matrix tissue after the removal of vascular tissues, allantoic duct, 
and amniotic epithelium, thereby eliminating any potential contamination and residual 
components. Our method results in an acellular matrix, with the innate properties of WJ as 
evidenced by histology and electron microscopy. Additionally, we demonstrated that this 
decellularization process results in a matrix material with negligible DNA content, consistent 
with current recommendations for qualifying as decellularized tissue [179]. 
 Mass spectrometry analysis demonstrated a presence of various proteins like collagen, 
fibronectin, lumican, and tenascin, which are important extracellular matrix proteins desirable in 
a scaffolding material for tissue engineering. Fibronectin has been shown to enhance the quality 
of scaffolding material used for osteogenic differentiation [180]. Lumican is a matrix protein that 
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has been correlated with in vivo bone formation by osteospheroids prepared in vitro from human 
mesenchymal stem cells[181]. Tenascin was found to be overexpressed when fibroblast cells 
were cultured in porous poly-caprolactone-based scaffolds and under torsion in a bioreactor 
[182]. TGF-β was identified in these scaffolds, which also happens to be an important factor in 
chondrogenic differentiation of MSCs as it enhances COL2A1 expression at the expense of 
COL1A1[183]. The impact of TGF-β on MSC differentiation is not limited to chondrogenic 
differentiation as it also plays a role in regulating osteogenic differentiation [184]. DWJM also 
contains sulfated GAGs, which are reported to enhance mesenchymal stem cell osteogenic 
differentiation in addition to improving cell-matrix interactions [185]. Similarly, GAGs were 
found to promote chondrogenic differentiation of human mesenchymal stem cells[186]. GAGs 
like chondroitin sulfate were also found to enhance the biological activity of collagen I scaffolds 
in supporting chondrocytes [187].    
When the WJMSCs were cultured on DWJM, there was immediate attachment and 
penetration of the seeded cells into deeper parts of DWJM scaffolds. Despite the uniform 
distribution of WJMSCs within DWJM scaffolds while seeding, some surface areas of DWJM 
attracted WJMSCs in clusters while some areas had cells growing in layers. In contrast, 
mesenchymal cell condensation has been reported to occur early in process of chondrogenesis, 
where mesenchymal cells produce matrix proteins including collagen I and fibronectin while 
extracellular matrix proteins  (e.g., tenascin) interact with cell adhesion molecules and initiate the 
transition to committed chondrocytes [188] TGF-βI has a role in inducing pre-cartilage 
condensation [189] and the DWJM matrix has retained TGF-β and other matrix proteins like 
collagen, fibronectin, and tenascin I. Therefore, we postulate that these proteins might have 
provided critical cues resulting in the WJMSCs developing areas of cell condensation.  We also 
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hypothesize that further tuning of the preparation process to yield symmetrical surfaces might 
allow for equal cell penetration or enhance cell condensation for specific tissue regenerative 
purposes.  
Our results show differences in the rate of proliferation between cells cultured in three 
dimensions (3D) versus 2 dimensions (2D). WJMSCs cultured in 2D grow horizontally to 
confluence while; WJMSCS on 3D grow in clusters, attach and penetrate into DWJM. Cells in 
3D also demonstrated a decrease in expression of the Ki-67 gene, a marker of proliferation, 
thereby indicating that the MSC proliferation slows down as cells interact with DWJM scaffolds. 
Therefore, we show that WJMSCs and BMMSCs can be seeded on DWJM and cultured, 
although they have a slower proliferative rate compared to the monolayer cultures.  This similar 
impact of culture condition (2D versus 3D) on the rate of cell proliferation was examined 
previously with some studies showing that 3D culture conditions were found to slow down cell 
proliferation [190]  
Wang et al. described that WJMSCs express matrix receptors like CD 44 and Endoglin 
(CD 105) [191]. Although BMMSCs physiologically do not express CD 44 in human or mice, 
Qian et al. demonstrated that in vitro culture of these MSCs could result in CD 44 expression. 
[192-194]. In our study, we observed increased expression of CD 44 gene in WJMSCs and 
BMMSCs cultured in DWJM over 7 days culture. CD 44 is a cell adhesion receptor involved in 
interacting with multiple ligands like hyaluronan, fibronectin and collagens [195]. The mass 
spectrometry analysis of DWJM identified fibronectin and collagen as components of the matrix 
while other researchers have also shown that hyaluronic acid is the most abundant component of 
the glycosaminoglycans in the Wharton’s jelly matrix [196]. Similarly, the decellularization 
process adopted in this work also showed that DWJM matrix retained hyaluronic acid 
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abundantly. Thus, the induction of CD44 in both the MSCs cultured on DWJM could possibly be 
associated with anchoring of the cells to hyaluronic acid in the matrix. Cell surface markers like 
Thy1, Endoglin, ALCAM, CD44 and VCAM have been used to isolate homogeneous MSC 
population [192, 197, 198].  When BMMSCs were cultured over DWJM, no significant changes 
in gene expression were noticed for genes Endoglin, and cell adhesion molecules – Thy 1 and 
ALCAM, while WJMSCs showed decreased expression of these genes. These subtle differences 
in the expression of the adhesion genes between WJMSCs and BMMSCs could be attributed to 
WJMSCs being native to the Wharton’s jelly matrix, while BMMSCs are being introduced into a 
new environment. 
RUNX2 is the most studied transcription factor expressed in MSCs upon their 
commitment to osteogenic differentiation [199, 200] while, SOX9 inhibits RUNX2, thus 
blocking the osteoblastic maturation during chondroprogenitor fate determination [201]. Loebel 
et al. has shown that SOX9 is an early indicator during in vitro osteogenic differentiation of 
MSCs and that the RUNX2/SOX9 ratio can be used to screen for osteogenesis [202]. In 
WJMSCs cultured over DWJM, we observed an increase in the expression of SOX9, while the 
RUNX2 expression was decreased. However, BMMSCs exhibited an increase in SOX9 and 
RUNX2 expression. Despite these differences, the ratio of RUNX2/SOX9 showed the same 
decreasing trend for WJMSCs and BMMSCs cultured over DWJM (WJMSCs: 3.26 at day 4 to 
0.62 at day 7; BMMSCs: 0.34 at day 4 to 0.16 at day 7) thereby indicating non-commitment to 
osteogenic lineage. Several researchers have already demonstrated the potential of WJMSCs 
differentiation into myogenic lineage in vitro and in vivo [203, 204]. BGN, a critical protein for 
collagen fibril assembly and muscle regeneration and ACTA 2, a protein essential for 
maintaining cell motility, structure and integrity were significantly down regulated in both the 
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MSCs over time.  Using gene expression studies, we conclude that WJMSCs and BMMSCs 
cultured in DWJM show no lineage specific differentiation towards osteogenic, chondrogenic, 
myogenic or adipogenic genes, thereby demonstrating that DWJM facilitated the cells to remain 
undifferentiated.  
We also transplanted the DWJM scaffold in a 5 mm cranial defect in mice with GFP 
labeled osteocytes and showed the migration of cells into the matrix as early as 24 hours by 
immunohistochemistry, and at 2 weeks by in vivo live imaging. Thus, DWJM was a 
biocompatible matrix that attracted cells from the surrounding tissues. Therefore, we corroborate 
that DWJM scaffolds are biocompatible and have favorable surgical characteristics like porosity, 
elasticity, and compressibility, which make it easy to configure in irregular or curved shapes. 
Based on these characteristics, we envision DWJM scaffolds will have several potential 





In this chapter we have demonstrated the successful isolation and decellularization of 
human WJ matrix and characterized this matrix as a potential candidate for use as a scaffolding 
material for future tissue engineering applications. We show that this naturally obtained matrix 
can be made completely devoid of cells but comprised of glycosaminoglycans especially rich in 
hyaluronic acid and several other key extracellular matrix proteins. We also demonstrate that 
DWJM is a biocompatible matrix that allows cellular adherence, penetration, growth and 
proliferation with suitable mechanical properties in vitro and in vivo. Together, this chapter 
presents DWJM as a novel and natural 3D scaffold that can be evaluated for tissue engineering 



















Figure 5 - Characteristics of decellularized Wharton's jelly matrix (DWJM).  
A) A fragment of the isolated DWJM. 5-7 mm in diameter pieces were obtained using a 5-7 mm skin 
punch biopsy kit, (right lower corner image). B) H&E stained sections of the DWJM showing empty 
spaces. (Scale bar represents 0.1 mm). C) Hyaluronic acid immunohistochemistry images of DWJM 
indicating abundant hyaluronic acid expression at one region and less abundant at the other. (Scale bar 
represents 25µm). D) Scanning electron microscopy pictures of DWJM. One surface appeared flat with 
compact matrix (left lower image) while, less dense tissue with open spaces was identified in other areas 
(lower right and middle images). (Scale bar for the full picture was 600 µm). E) Transmission electron 
microscopy pictures of DWJM. More electron dense areas of DWJM (left upper image) and less electron 
dense areas (right upper image) were observed. No intact cells were observed in all the panels. (Scale bar 







Figure 6 - Assessment of decellularized Wharton's jelly matrix.  
A) DNA quantification study performed on the matrix before decellularization and after 
decellularization. DWJM showed a significantly lesser DNA compared to the native WJ matrix 
before decellularization.  B) Glycosaminoglycan contest assessment of the matrix before and 








Figure 7 - MSC characterization by flow cytometry. 
 A) Wharton’s jelly mesenchymal stem cell (WJMSCs) and, B) Bone marrow mesenchymal stem 
cell (BMMSCs). All the MSCs stained positive for CD 90 (FITC), CD 105 (PE) and CD 73 
(APC), and were negative for CD 45(Per CP), CD 34(Per CP), CD 14 or CD 11b (Per CP) and 















Figure 8 – WJMSCs and DWJM in vitro interactions.  
Confocal microscopy images of WJMSCs on DWJM after 2 hours (upper panel), 1 day (center 
panel), and 2 days (lower panel) of cell seeding. Calecin AM was used to label the cells and 







Figure 9 – MSCs and DWJM interactions.  
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Dual beam microscopy imaging of DWJM with and without MSCs.  
Images A-E is on the ETD detector and F-J is using the CBS detector respectively.  (A, F) 
DWJM with no cells seeded into the matrix. (B, G) DWJM with WJMSCs seeded for 1 day, (C, 
H) DWJM with WJMSCs seeded for 7 days, D, I) DWJM with BMMSCs seeded for 1 day, and 
E, J) DWJM with BMMSCs seeded for 7 days. A* and F*) 10X magnification of inset in panel 
A and F respectively; B* and G*) 5X magnification of inset in panel B and G respectively; C* 
and H*) 5X magnification of inset in panel C and H respectively; D* and I*) 5X magnification 
of inset in panel D and I respectively; E* and J*) 5X magnification of inset in panel E and J 
respectively. B#-E# and G#-J# are the low power magnification of images B-E depicting MSCs 
seeded on DWJM. The Everhart-Thornley detector (ETD) is a standard secondary electron 
detector used in scanning electron microscopy to study the topography, while the circular 
backscatter (CBS) is a backscatter detector that reveals lipid content when samples are stained 
with osmium Tetroxide (OT). Images have been pseudo-colored to enhance definition 
proportional to secondary electron signal for ETD and to identify backscatter signal for the CBS 
detector. Red coloring represents lipid content for samples imaged with the CBS detector. 
Orange Arrows correspond to the outer edge of the DWJM. White Arrows correspond to positive 
lipid staining. Yellow Scale Bar = 100 µm. Orange Scale Bar = 50 µm. Red Scale Bar = 20 µm. 



















Figure 10 – WJMSCs and DWJM interactions. Time lapse imaging of WJMSCs 
seeded on DWJM.  
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Images 1-4 A represent bright field image of WJMSCs on DWJM, 1-4 B represents labeled 
WJMSCs, 1-4 C are labeled DWJM and 1-4 D shows labeled WJMSCs on DWJM. Figure 10-
1A-1D, 2A-2D, 3A-3D, 4A-4D are WJMSCs on DWJM at time 0 hour, 6 hours, 12 hours and 18 
hours, respectively. WJMSCs can be seen proliferating and migrating inside and outside the 
DWJM. Figure 10-5 represent WJMSCs at three different depths in the matrix as Z–1, Z 0, Z+1. 
The upper panel represents labeled WJMSCs on DWJM, while the lower panel demonstrates 
labeled DWJM. WJMSCs are labeled in burgundy color and DWJM is labeled in green. 
WJMSCs on DWJM are in yellow color. Scale bar = 100 µm.  







Figure 11 - WJMSC proliferation following seeding onto DWJM and transmigration toward 
DWJM.  
A) Alamar Blue assay to assess the viability of cells seeded on the matrix and B) Cell migration 
assay performed using trans-wells with cells alone (control) and cells migrating towards DWJM 





Figure 12 - Differentiation potential of WJMSCs seeded onto DWJM. 
Panel A-F are relative gene expression of WJMSCs seeded on DWJM for A) Cell adhesion 
genes, B) Chondrogenic genes, C) Adipogenic genes, D) Myogenic genes E) Osteogenic genes, 
F) Apoptosis and proliferation genes. The relative fold change is represented on the y-axis and 
all the experiments were conducted in triplicates (n=3).  The horizontal line represents the gene 






Figure 13 –Differentiation potential of BMMSCs seeded onto DWJM.   
Panel A-F are relative gene expression profiles when BMMSCs are cultured on DWJM for A) 
Cell adhesion genes, B) Chondrogenic genes, C) Adipogenic genes, D) Myogenic genes E) 
Osteogenic genes, F) Apoptosis and proliferation genes. The relative fold change is represented 
on the y-axis and all the experiments were conducted in triplicates (n=3).  The horizontal line 




Figure 14 - DWJM transplantation in a cranial defect mouse model.  
A) Mice with cranial defect, B) mice with defect and DWJM, C) mice with defect and DWJM 14 
days post-surgery. Arrows in A represent the defect, B shows the DWJM and C is the defect and 
DWJM 14 days post-surgery. D) IVIS imaging of the mice post – surgery - 1) Mice with DWJM 
24 hours post surgery; 2-6 designates mice 14 days after the surgeries. D2 is mice without any 
intervention, D3 and D4 are mice with the defect alone and D5 - D6 represents mice with defect 
and DWJM. The red circles indicate the defect sites. The green fluorescence signal at the defect 
site signifies the migration of the GFP positive cells into the defect. Images E-J represent the 
histology images of bone specimen with DWJM 14 days post surgery, with image E) H&E 
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section of DWJM tissue specimen 24 hours post surgery and image F depicts the GFP 
immunohistochemistry staining of the same. Images G-J represent DWJM sample 14 days post 
surgery respectively, at different magnifications as indicated. The arrows in image F, J represent 
GFP positive cells. The arrows in Image G indicate the beginning and end of defect while black 




Table 2 - Real time PCR TaqMan primers and their description.  
Gene 
symbol 
Detector Gene name 
GAPDH GAPDH-Hs99999905_m1 Glyceraldehyde-3-phosphate 
dehydrogenase 
ACAN ACAN-Hs00153936_m1 Aggrecan 
SOX9 SOX9-Hs00165814_m1 SRY (sex determining region Y)-box 9 
COL2A1 COL2A1-
Hs00264051_m1 
Collagen, type II, alpha 1 
ALPL ALPL-Hs01029144_m1 Alkaline phosphatase, liver/bone/kidney 
RUNX2 RUNX2-Hs00231692_m1 Runt-related transcription factor 2 
ITGB1  ITGB1-Hs00559595_m1 Integrin, beta 1 (fibronectin receptor, beta 
polypeptide, antigen CD29 includes 
MDF2, MSK12) 
CD44  CD44-Hs01075861_m1 CD44 molecule (Indian blood group) 
THY1  THY1-Hs00174816_m1 Thy-1 cell surface antigen 
ENG  ENG-Hs00923996_m1 Endoglin 
ALCAM ALCAM-
Hs00977641_m1 
Activated leukocyte cell adhesion 
molecule 
CD14  CD14-Hs00169122_g1 CD14 molecule 
MKI67 MKI67-Hs01032443_m1 Antigen identified by monoclonal 
antibody Ki-67 
BAX BAX-Hs00180269_m1 BCL2-associated X protein 
VIM  VIM-Hs00185584_m1 Vimentin 
ACTA2
  
ACTA2-Hs00426835_g1 Actin, alpha 2, smooth muscle, aorta 





Collagen, type I, alpha 1 
COL4A1 COL4A1-
Hs00266237_m1 
Collagen, type IV, alpha 1 
COL6A1 COL6A1-
Hs01095585_m1 
Collagen, type VI, alpha 1 
DES  DES-Hs00157258_m1 Desmin 
HAS2  HAS2-Hs00193435_m1 Hyaluronan synthase 2 
BGN  BGN-Hs00156076_m1 Biglycan 
VCAM1 VCAM1-Hs01003372_m1 Vascular cell adhesion molecule 1 
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NOS3  NOS3-Hs01574659_m1 Nitric oxide synthase 3 (endothelial cell) 




Table 3 - Proteins identified in DWJM using mass spectrometry. 













3(VI)   
219521324 13.70 278.0 8.15 18 18 
Collagen type I 
alpha-1 
110349772 6.01 138.8 5.80 7 2 
Collagen type I 
alpha 1   
180392 9.13 98.5 6.83 7 2 
Collagen, type 
VI, alpha 1 
119629727 12.06 108.5 5.43 8 8 
 Human Serum 
Albumin 
55669910 16.78 65.2 5.80 7 7 
Collagen type I 
alpha 2 




115527062 13.74 108.5 6.21 8 8 
Fibronectin 1  219518912 5.38 239.5 5.88 5 5 
G-gamma-
hemoglobin  








Tenascin C  156229767 4.93 210.4 4.98 4 4 
TGFBI 221044656 19.25 55.7 6.84 4 4 
Lumican  4505047 15.68 38.4 6.61 3 3 
Collagen, type 
III, alpha 1 
119631314 2.66 106.3 8.10 2 2 
Osteoglycin  55957237 13.06 30.4 8.34 3 3 
TGFBI 37589544 3.00 75.1 7.23 1 1 
Actin, alpha 119612724 12.50 30.3 5.00 2 1 
Beta actin, 
gamma 1 
194375299 10.21 37.3 5.71 2 1 
HCG2044004  119628289 46.88 3.6 9.32 1 1 
Collagen, type 
XII, alpha 1, 
isoform CRA_c  
119569135 2.22 333.0 5.53 3 3 
Hemoglobin 
alpha 2  
13958153 59.21 8.4 7.14 2 2 
Immunoglobulin 
heavy chain 
variable region  
145911949 33.33 9.6 6.52 1 1 
Ig G1 H Nie 229601 3.57 49.2 8.54 1 1 
Decorin 119617856 14.29 28.0 8.13 2 2 
Unnamed 
protein product  
40036688 17.72 17.8 8.38 1 1 
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N6AMT2 119628685 29.07 9.8 4.36 1 1 
Dynein, 
axonemal, 
heavy chain 14  
220732359 5.31 40.7 5.21 1 1 
Chain D, 
Crystal 
Structure Of A 
Sparc-Collagen 
Complex 

















1082874 3.18 85.4 7.77 1 1 
PLEKHG3 
protein  
120537866 3.32 80.8 5.40 1 1 
OPK V NimA 
family  




isoform CRA_c  
119599646 1.09 193.4 6.96 1 1 
CDH24 28375477 10.79 26.3 5.43 1 1 
Beta IV spectrin 
isoform sigma3  
11602888 1.76 148.5 6.37 1 1 
FBLN1 22761800 3.61 70.5 5.91 1 1 
Unnamed 
protein product  
40035675 3.16 68.9 9.32 1 1 
Immunoglobulin 
heavy chain 
variable region  
13171510 52.73 6.2 8.76 1 1 
Periostin 
isoform thy8  




33589848 3.37 88.7 6.11 1 1 





62089380 1.95 101.4 9.22 1 1 
Truncated beta-
globin  
58201131 47.50 4.5 9.47 1 1 
Dermatopontin 27151769 39.8 24 4.82 4 4 
  





Ig kappa chain 
C region 
125145 32.08 11.6 5.87 2 2 
Fibrinogen beta 
chain 
399492 26.68 55.9 8.27 6 6 
Fibrillin-1  311033452 17.69 312 4.93 25 25 
Apolipoprotein 
A-I isoform X2 
[Homo sapiens] 
530398069 15.73 30.8 5.76 3 3 
Ig gamma-1 
chain C region  




sapiens]          
530391203 11.74 33.9 5.63 2 2 
Fibrinogen 
gamma chain  
20178280 9.05 51.5 5.6 2 2 
Keratin, type I 
cytoskeletal 9 





















Abbreviations: TGFBI: transforming growth factor, beta-induced, FBLN1: fibulin-1, H2AFJ: histone H2A.J. 
 





120042 6.4 68.6 5.68 2 2 
Keratin, type II 
cytoskeletal 1 
238054406 5.59 66 8.12 3 3 
Versican core 
protein 
2506816 2.06 372.6 4.51 3 3 
Fibrillin-2 238054385 1.03 314.6 4.86 2 2 
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Chapter 3: Decellularized Wharton’s jelly matrix as a Three-Dimensional Scaffold for 
Ectodermal Differentiation of WJMSCs.3 
Introduction 
The mammalian hair follicle development begins towards the end of the first trimester of 
pregnancy and their number remains the same thereafter [205]. Hair regeneration occurs in three 
phases: anagen (the growth phase), telogen (the resting phase) and catagen (the regression 
phase). Loss of an adult hair follicle from head or body is considered permanent and a complete 
loss of hair follicles observed in cases of severe burn victims and baldness is associated with 
mental stress [111]. The therapeutic treatment for hair loss involves transplantation of natural 
hair from hair rich occipital areas to hair deficient sites, although this surgery is limited by the 
availability and the ability to transplant hair [206]. Currently researchers are trying to revive hair 
follicles by in vitro culturing of hair follicle cells and implanting them at the treatment area [207-
209]. The local dermal-epidermal interaction control hair growth, while the dermal papilla, a 
condensation of cells at the base of the hair follicle actively promotes follicle induction and hair 
fiber growth [73, 210]. Hence, difficulties in obtaining good quality and sufficient number of 
dermal papilla cells along with maintaining the trichogenic ability of these cells poses to be the 
biggest challenge [62, 73, 209, 211]. WJMSCs are abundantly available in Wharton’s jelly (the 
mucoid porous connective tissue of the human umbilical cord), can be easily obtained and are 
being increasingly recognized for their ectodermal differentiation potential [111, 212].  
                                                
 
 
3	Published as, Jadalannagari S, Berry AM, Hopkins RA, Bhavsar D, Aljitawi OS, “ Potential 
mechanisms underlying ectodermal differentiation of Wharton’s jelly mesenchymal stem cells”, 
Biochemical and biophysical research communications, August 2016.	
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Aljitawi et al. previously demonstrated that WJMSC cultured on DWJM in osteogenic 
differentiation media differentiate into hair-like structures with CK19 positive cells [213]. 
Herein, we further examined WJMSC differentiation into hair-like structures and CK19 positive 
cells and explored the molecular mechanisms that potentially explain ectodermal differentiation 
in our model. It is well documented that communication between different pathways like the 
Wnt/ β-catenin, TGF- β and BMP4 pathways is critical for hair follicle development. β-catenin is 
an effector of intercellular adhesion and functions in Wnt signaling pathway along with Lef-
1/Tcf DNA binding proteins, to form a transcription factor. Gat et al. reported that this pathway 
operates in keratinocytes and showed that mice expressing stable β-catenin undergo a process 
resembling de novo hair morphogenesis [214]. It is also shown that Wnt pathway is active in 
both epithelial and mesenchymal components of developing follicles [215].  Post natally, 
initiation of new hair growth phase requires neutralization of the inhibitory activity of bone 
morphogenetic protein 4 (BMP4) by the BMP antagonist noggin. During telogen, BMP4 mRNA 
predominates noggin in epithelium and mesenchyme with BMPR1A expressed in the follicular 
germ while, through anagen, BMP4 is down regulated, and noggin mRNA is increased.  As a 
hair growth inducer, noggin increases Sonic Hedge Hog (SHH) mRNA in hair follicle, while 
BMP4 down regulates SHH [92, 216]. The morphogen SHH of the Hedge Hog family is 
generated in the hair follicle placode and is known for regulating hair follicle epithelial growth 
[100, 217]. Woo et al. demonstrated that SHH acts directly on the dermal condensate and helps 
in maintaining dermal condensate cell identity and maturation during hair follicle morphogenesis 
[218]. SHH and Noggin form a positive loop in hair development [92, 216], while Noggin and 
BMP6 (maintains dermal papilla hair inductive function) constitute part of a negative feedback 
loop regulating hair outgrowth [219].  
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Plikus et al. has demonstrated that at the start of telogen, intradermal BMP levels are 
high, which gradually decrease towards the onset of anagen. During telogen, the dermal papilla 
produces a high level of BMP inhibitors like noggin, to reduce BMP threshold and maintains 
stem cell quiescence [220].  Oshimori et al. has shown that TGF-β2 plays an important role in 
dampening BMP signaling thereby promoting hair follicle stem cell activation. They also proved 
that the stem cell activation is a result of a comprehensive niche in which TGF-β2 functions 
specifically at quiescence to activate the stem cells in a short – range, concentration – dependent 
fashion [104].  Smads are a group of signaling mediators and antagonists of TGF-β2, activin and 
BMPs [221].  It has been previously shown that TGF-β2 activates Smad 2/3 transiently in hair 
follicle stem cells during tissue regeneration [104].  Smad 4 affects hair follicle differentiation by 
mediating BMP signaling and Smad-7 significantly affects hair follicle development and 
differentiation by blocking TGF-β/Activin/BMP pathway along with inhibiting Wnt/ β-catenin 
signaling via ubiquitin-mediated β-catenin degradation [221].  Thus, in this chapter, I will be 
exploring the molecular mechanisms associated with differentiation of WJMSCs seeded on 





Materials and Methods  
Human umbilical cord collection, WJMSCs isolation and harvesting of decellularized 
Wharton’s jelly tissue were performed according to the IRB protocol # HSC 12129 of the 
University of Kansas Medical Center. Umbilical cords were collected immediately after normal 
vaginal delivery from consented donor mothers with full-term pregnancy. The umbilical cord 
was placed in a transport solution made of Lactated Ringer’s solution supplemented with 
penicillin 800 U/ml (Sigma-Aldrich, St. Louis, MO), streptomycin 9.1 mg/ml (Sigma-Aldrich), 
and amphotericin 0.25 mg/ml (Sigma-Aldrich) and immediately refrigerated at 4°C. The 
decellularization process was initiated within 72 hours of umbilical cord collection.  
Decellularization process 
The decellularization procedure was carried out as described in our earlier publication 
[169]. Briefly, umbilical cords were dissected and were subjected to two cycles of osmotic 
shock, by alternating with a hypertonic salt solution containing sodium chloride, mannitol, 
magnesium chloride, and KCl. The tissues were further subjected to an anionic detergent 
(Sodium lauryl) and, sodium succinate (Sigma L5777), alternating with a recombinant nucleic 
acid enzyme, (Benzonase™) in buffered (Tris Hcl) water for 16 hours.  Following this, an 
organic solvent extraction was done and all of the detergent and other processing residuals were 
then removed utilizing ion exchange beads. The decellularized matrix was cryopreserved using 
10% human recombinant albumin (Novozymes) and 10% DMSO (Sigma) solution in standard 
RPMI media, employing a material specific computer controlled freezing profile that was 





Isolation, expansion, and MSCs seeding onto scaffolds 
Preparation of DWJM for seeding with MSCs 
Freshly obtained fragments of DWJM were transferred to a large petri dish and covered 
with phosphate buffered saline (PBS). DWJM pieces (5-7mm in diameter) were obtained using a 
sterile 5-7 mm skin punch biopsy kit. The resulting DWJM pieces were cylindrical in shape with 
non-uniform heights, which varied between 2-3 mm. The volume of the obtained DWJM 
scaffolds’ was ~72 mm3. From this point on, these pieces of DWJM will be referred to as DWJM 
scaffolds. DWJM scaffolds were transferred using sterile forceps to a large petri dish and washed 
with PBS twice.  At the time of seeding, the DWJM scaffolds were transferred to non-tissue 
culture treated plates.     
Preparation of Dermal graft for cell seeding  
The Alloderm® dermal grafts (DG) were purchased from Life cell Inc. (Bridgewater, 
NJ). 7 mm scaffolds 150-250 µm in thickness were obtained using a sterile 5-7 mm skin punch 
biopsy kit. These scaffolds were soaked in sterile PBS solution before using for rehydrating the 
tissue in vitro and in vivo.  
MSC isolation and expansion 
a. WJMSCs  
WJMSCs were isolated and expanded according to the procedures described by Wang et 
al. [171]. Briefly, the outer layer of the cord was carefully removed and the cord was cut into 
smaller segments. The blood vessels were dissected from these cord segments and then cut into 
smaller pieces and digested with Collagenases (Worthington Biochemical Corporation, 
Lakewood, NJ) in low glucose DMEM (Sigma-Aldrich) with 10% FBS (Atlanta Biologics, 
Atlanta, GA) and 1% Penicillin/Streptomycin (Sigma-Aldrich) overnight at 37° C to obtain 
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WJMSCs. The WJMSCs were passaged and maintained in low glucose DMEM with 10% FBS 
and 1% Penicillin/Streptomycin (also called as regular media (RM)). WJMSCs from passages 4 - 
9 were used for the experiments. The WJMSCs were also cultured in hair follicle derma papilla 
cell growth media (HFDPM) (Cell Applications Inc., San Diego, CA) with 10% FBS and 1% 
Penicillin/Streptomycin for 2 weeks. 
b. BMMSCs  
BMMSCs were isolated from bone marrow aspirates of healthy consented donors at 
University of Kansas Medical Center (HSC # 5929). The cells are isolated following standard 
ficoll density gradient separation method (Lymphoprep, Stem cell technologies, Vancouver, BC). 
The isolated cells were counted and plated to select for MSCs based on adherence to plastic in 
culture flasks. The adherent cells were maintained in high glucose DMEM (Sigma-Aldrich), 20% 
FBS (Atlanta Biologics) and 1% Penicillin/Streptomycin (Sigma-Aldrich) at 37°C, 5% CO2 and 
90% humidity.   
MSC characterization and phenotyping  
MACS Miltenyi Biotec MSC human phenotyping kit was used for the characterization of 
expanded WJMSCs and BMMSCs. Flow cytometry analysis was performed using BD Flow 
cytometer LSR2. MSCs isolated from human umbilical cord and bone marrows were stained for 
CD14, CD20, CD34, CD45, CD73, CD90 and CD105.  
MSC seeding onto scaffolds  
 For each set of seeding experiments, single-donor (n=1) WJMSCs/BMMSCs was used. 1 
x 106 MSCs were suspended in 100µl culture medium and seeded on each DWJM 
scaffold/dermal graft scaffold (average seeding density was 1.4 X 104  - 4 x 104/mm3 DWJM 
scaffold) in a 24-well non tissue culture treated plate. 1 ml of medium/well was added to the cells 
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on the scaffolds. After 2 days, the media was changed to osteogenic differentiation media (OD) 
composed of the regular media with 100nM dexamethasone (Sigma-Aldrich, St. Louis, MO), 
5mM β-glycerolphosphate (Sigma-Aldrich, St. Louis, MO), 10nM 1α 25 di-hydroxy vitamin D3 
(Enzo life sciences, Farmingdale, NY), 50µg/ml ascorbic acid 2-phoshate (Sigma-Aldrich, St. 
Louis, MO) and the cells were cultured for 4 weeks.  For the gene expression studies, 0.25 – 1.0 
x 106 WJMSCs/BMMSCs of passage 4-7 were seeded on DWJM on a 24-well non tissue culture 
treated plate (Corning Inc., Corning, NY) for 2-4 weeks and cultured in their respective media. 
Samples were harvested at day 0, week 2 and week 4. Day 0 was used as the control for all the 
qPCR analysis (Figure 15). 
Evaluating seeded WJMSC adherence to DWJM, proliferation and characterization of the 
hair-like structures 
Confocal microscopy  
 To assess WJMSC attachment to DWJM scaffolds, 1 x 106 WJMSCs were seeded on 
each DWJM scaffold in a 24-well culture plate. After 4 weeks of cell culture, these scaffolds 
were viewed using Fluoview scanning laser confocal microscope (Olympus, Center Valley, PA). 
Prior to viewing, seeded DWJM scaffolds were rinsed twice with PBS and incubated with 
culture medium containing 2 µg Calcein AM stain (Molecular Probes, Eugene, OR). Calcein 
AM is a cell-permeant dye that is converted to green-fluorescent Calcein in live cells.  
Scanning electron microscopy (SEM)  
DWJM scaffolds were fixed in 2 % glutaraldehyde for SEM processing. The fixed 
samples were washed with PBS for 10 minutes, placed into buffered 1% osmium tetroxide for 1 
hour, and then washed 3 times 10 minutes each in distilled water. Further, the samples were 
dehydrated through a graded series of ethanol from 30%, 70%, 80%, 95%, and 100% for 15 
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minutes each. Following this, the samples were critical point dried in CO2 in a model EMS 850 
dryer, then they were mounted onto aluminum mounts and sputter coated with gold in a Pelco 
SC-6 sputter coater. Finally samples were viewed using a Hitachi S-2700 scanning electron 
microscope. 
Histology and Immunohistochemistry  
DWJM/Dermal graft scaffolds were fixed in 10% formalin or 4% paraformaldehyde for 
24hours, embedded in paraffin, sectioned with an average thickness of 40 µm, and stained with 
H&E. Slides were reviewed using Olympus BX40 microscope and pictures were acquired using 
DP72 digital camera. 
Immunohistochemistry staining was performed using IntelliPATH FLX™ automated 
stainer (Biocare Medical, Concord, CA) at room temperatures. Briefly, after deparaffinization 
and rehydration, tissue sections were separately incubated with primary antibodies against 
Cytokeratin 19 (1:50 dilution; Biocare Medical, Concord, CA), collagen 1 (Abcam, Cambridge, 
MA), and Smooth muscle actin (SMA) (1:500 dilution, Dako, Carpinteria, CA) for 30 minutes 
are room temperature respectively. After rinsing, CK19 and SMA sections were incubated with 
anti-mouse HRP-labeled polymer (EnVision™ + system, Dako, Carpinteria, CA) while collagen 
1 sections were incubated with MACH 2™ rabbit HRP-polymer (Biocare Medical, Concord, 
CA). Finally, the staining was visualized by DAB (Dako, Carpinteria, CA) and nuclei were 
counterstained with hematoxylin. Β-catenin immunohistochemistry was done using mouse anti-





RNA extraction from cells 
WJMSCs and BMMSCs were cultured as a monolayer (2D) or on DWJM/dermal graft 
(3D) as described above. WJMSCs were harvested from the scaffolds following overnight 
digestion with Collagenase II. The MSCs were washed twice with PBS and centrifuged at 13000 
rpm, 4°C for 20 minutes to obtain a cell pellet. The cell pellet was suspended in 1 ml of Trizol 
(Life technologies) and stored at -80°C until further processing. Once all the samples were 
collected, RNA was extracted using the standard procedure as described by the manufacturer 
(Life technologies, Carlsbad, CA). Briefly, aqueous phase containing RNA was separated using 
0.2 ml chloroform, 0.7 volumes of isopropanol was added and centrifuged to precipitate RNA. 
The RNA pellet was washed twice with 75% ethanol and dissolved in 30-50µl of nuclease free 
water. RNA was quantified using Nano drop spectrophotometer 8000. 1.5µg of RNA was treated 
with DNA-freeTM DNase treatment and removal kit (Life Technologies).  High capacity cDNA 
reverse transcription kit (Applied Biosystems) was used to generate cDNA from the extracted 
total RNA samples using Bio-Rad T100 thermal cycler. 
Quantitative real-time PCR analysis 
The quantitative real-time PCR (qPCR) reactions (20 µl) were performed with TaqMan 
gene expression master mix (Life Technologies), and TaqMan array 96 well plates (Applied 
Biosystems, Foster City, CA) using StepOnePlusTM real-time PCR system (Applied Biosystems). 
The primers used are described below in (Table 4). The qPCR reactions were performed in 
triplicate. StepOnePlusTM real-time PCR system (Applied Biosystems) was used for the qPCR. 
GAPDH was used as an internal control to normalize the samples to obtain ∆Ct. 2-∆∆Ct was used 
to analyze the relative gene expression levels.  
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Immunoblot analysis  
For immunoblot analysis of β-catenin, BMP4, SMAD, WJMSCs and BMMSCs were 
cultured with or without DWJM and with or without osteogenic differentiation media for 4 
weeks. Immunoblot for each condition was performed in experimental triplicates. Following the 
differentiation, DWJM was digested with collagenase (Worthington Biochemicals, Lakewood, 
NJ) over night at 37°C and the obtained cells were washed twice with 1× PBS. Protein was 
harvested using ice-cold RIPA buffer containing protease and phosphatase inhibitor cocktail 
following three freeze thaw cycles at -196°C and 37°C respectively. Cell lysates were collected 
and the protein concentrations were determined using DC Protein assay kit (Bio-Rad, Hercules, 
CA). 20 µg of cell lysate was resolved on a 4-12% Bis-Tris gel (Invitrogen, Carlsbad, CA) and 
then transferred onto a 0.22µ nitrocellulose membrane (Maine manufacturing). Novex XCell II™ 
Blot Module was used for the semi-wet transfer (Life technologies, Carlsbad, CA). The 
membranes were blocked with Odyssey® blocking buffer (Li-Cor, Lincoln, NE) washed with 1× 
TBS containing 0.1% tween 20 (TBST). Immunoblotting was performed using anti-β-catenin 
rabbit monoclonal antibody (dilution of 1∶1000) (8480, Cell signaling technology, Danvers, 
MA), anti-BMP4 rabbit monoclonal antibody (dilution of 1:1000) (ab124715, Abcam, 
Cambridge, MA), and anti-Smad polyclonal goat antibody (AF3797, R&D systems, 
Minneapolis, MN) at 1:1000 dilutions in blocking buffer. After multiple TBST washes, IRDye® 
800CW goat anti-rabbit IgG (Li-Cor, Lincoln, NE) and Pierce™ donkey anti-goat IgG (Thermo-
Scientific, Rockford, IL) (dilution 1:10000) were used respectively. Further, the blot was washed 




The membrane was stripped using Restore fluorescent stripping buffer (Thermo 
scientific, Rockford, IL) and re-probed for β-actin using rabbit anti β-actin antibody (dilution of 
1∶1000) (Cell signaling technologies, Danvers, MA) and IRDye® 800CW goat anti-rabbit IgG 
secondary antibody (Li-Cor, Lincoln, NE). Densitometry analysis was performed on all (n = 6) 
images using ImageStudio software. The intensities of proteins were normalized to their 
corresponding β-actin intensities. 
Statistical analysis  
All data were expressed as means ± standard error of mean (SEM) and analyzed using 
student’s t-test, two-way analysis of variance (ANOVA) with Bonferroni post-test. A threshold 
of p ≤ 0.05 was used to determine statistical significance. The statistical analyses were performed 






Regeneration of hair like structures  
Decellularized Wharton’s jelly matrix was used to culture WJMSCs in RM (Figure 16A) 
and OD (Figure 16B-D). WJMSCs cultured in OD, demonstrated some structures reproducibly 
protruding through the outer layers of DWJM. These structures were 10 - 30µ in length at week 2 
that increased to about 100µ at week 4 (Figure 16C-D). Also, some of these structures were 
coiled underneath the outer layer (Figure 16B) and others were around 30µ - 100µ in width 
(Figure 16D) at week 4. These structures were similar in diameter (11µ -100µ) to human hair 
follicles observed among various ethnic groups [223].  WJMSCs cultured on DWJM in media 
without the osteogenic components did not demonstrate these structures (Figure 16A). WJMSCs 
cultured on Alloderm, also appeared to grow on the Alloderm, and cellular condensations were 
observed between the edges of dermal graft, causing them to roll, but no hair like structures were 
noticed.  
After 4 weeks of culture, matrix without cells was observed under scanning electron 
microscope, and appeared like a randomly woven fibrous mesh (Figure 17A) while, WJMSCs 
cultured on DWJM in regular media appeared to attach and grow in the pores and on the surface 
of DWJM (Figure 17B). Two types of cells were observed - spherical and round in shape (Figure 
17B). WJMSCs cultured in osteogenic media also attached on the matrix and had a smooth 
appearance. Cells were undistinguishable and structures of sizes 30-100µ were observed 
protruding from the matrix (Figure 17C-D). 
When DWJM with differentiated cells was observed under a confocal microscope using 
calcein AM dye, cells aligned on the surface of DWJM and some cells were observed inside the 
matrix (Figure 18A-D).  Staining of dermal grafts seeded with cells also demonstrated presence 
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of live cells on the surface (Figure 18E-H). WJMSCs cultured on DWJM in osteogenic media 
also showed cells aligned on the surface and revealed that these structures were associated with 
live cells (Figure 18I-L).  
Evaluation of histology sections of the DWJM seeded with WJMSCs in RM and OD 
demonstrated that WJMSCs were present on the outer surface in multiple layers while in some 
areas they were more abundant and formed cellular condensations ( 
Figure 19A-F). Cells were also observed inside the pores of the matrix ( 
Figure 19C, F). Staining of DWJM without cells was negative for CK19 (marker of hair follicle 
stem cells and epithelial progenitors [224]) and smooth muscle actin (marker for hair follicle 
dermis [225]). Interestingly, WJMSCs cultured on DWJM for four weeks were CK19 positive 
(Figure 20A-D) indicating the possible ectodermal differentiation similar to keratinized hair. 
Aljitawi et al., also demonstrated that CK19 protein expression was increased over time when 
WJMSCs were cultured in OD. Staining of sections of DWJM seeded with WJMSCs for Smooth 
muscle actin (SMA), a marker for hair follicle dermis [225] revealed positive labeling for SMA 
suggesting enrichment of hair follicle dermis cells (Figure 20E-H). Staining with collagen 
revealed the matrix was rich in collagen and that the cells on the surface and inside the pores 
were also positive for collagen I (Figure 20I-L).  Finally, WJMSCs cultured on dermal graft also 
stained strongly for CK19 and SMA, suggesting potential ectodermal differentiation (Figure 20I-
P).  
Hair-like structure development on DWJM is a unique feature of WJMSCs alone 
When BMMSCs were seeded on DWJM and cultured similarly, they appeared to attach 
and occupied the matrix, although no hair like structures were observed. Similarly, when 
WJMSCs were cultured on dermal graft scaffolds, they occupied the matrix and proliferated, but 
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no hair like structures were observed. Thus, the hair like structures on DWJM appears to be a 
result of WJMSCs interaction with DWJM alone (Figure 22A-D).  
Hair-like structure is an attribute of osteogenic media 
WJMSCs cultured on DWJM in OD media developed the hair like structures, while 
commercially available hair inducing media did not have the potential for this differentiation 
(Figure 23). To further our understanding of the relative contribution of various osteogenic 
media components in ectodermal differentiation, we cultured WJMSCs on DWJM in osteogenic 
media eliminating a single component of the osteogenic media at a time. We observed that media 
without dexamethasone did result in hair like structures, while media lacking vitamin D3, 
ascorbic acid or β-glycerolphosphate did not (Figure 24). These results suggest that 
dexamethasone might not be a critical component in inducing ectodermal differentiation of 
WJMSCs.  
Exploring key factors in WJMSC-DWJM interactions  
The communication between the epidermis and the underlying mesenchyme initiates hair 
follicle morphogenesis. These interactions depend on the interplay of secreted molecules from 
Wnt/wingless family, the hedgehog family, members of TGF-β /BMP (Transforming growth 
factor-β/ bone morphogenetic protein), FGF (Fibroblast growth factor) and TNF (Tumor necrosis 
factor) families [67-69].   
β-Catenin  
Canonical Wnt/ β-catenin signaling acts as the primary switch for hair follicle fate. 
Absence or the inhibition of β-catenin by ectopic epithelial expression of the secreted Wnt 
inhibitor DKK1 results in lack of hair follicle induction [74, 75]. Conversely, forced expression 
of a stable form of β-catenin causes strong enhanced placode formation due to epidermal 
91 
 
keratinocytes globally adopting a hair follicle fate [76, 77]. β-catenin expression was studied by 
immunohistochemistry at week 2,4 and it was observed that WJMSCs on DWJM in OD stained 
positive for β-catenin while WJMSCs on DWJM and RM did not express β-catenin. The 
differentiated cells on the surface and inside the matrix stained positively for β-catenin 
implicating β-catenin in ectodermal differentiation of WJMSC towards hair follicle when 
cultured in DWJM (Figure 21A-F).  
From gene expression studies, we observed that WJMSCs cultured on DWJM in regular 
media decreased the expression of β-catenin mRNA at week 2 by 0.5 fold; while, osteogenic 
media increased the expression by 0.5 fold.  At week 4, there was a decrease in the expression of 
β-catenin mRNA, regardless of culture conditions, indicating that β-catenin is an early signal that 
that might contribute to the formation of hair-like structures in our model (Figure 25A). 
Immunoblot analysis of total β-catenin protein level was performed using whole cell lysate from 
WJMSCs cultured in the presence and absence of DWJM with RM/OD media. Densitometry 
analysis revealed significant increase in β-catenin expression at week 2 (4 fold for OD media), 
followed by a decrease at week 4 (0.25 fold for OD media) in 3D cultures, when compared to the 
control (2D culture) (Figure 26). Similar trend in modulation of β-catenin expression was 
observed for cells cultured in RM. However, the magnitude of alteration observed was much 
lower (week 2:1.2 fold increase and week 4: 0.75 fold decrease) as compared to OD media 
(Figure 26). This suggests that osteogenic media along with DWJM has a synergistic effect on 
expression of β-catenin.  
Noggin and BMP4 
 The mesenchyme expresses noggin, an extracellular BMP antagonist that induces hair 
follicle morphogenesis in the embryo and promotes new hair follicle growth post-natally [92, 
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93]. After the initiation of embryonic hair follicles is completed, BMP4 is expressed, activating a 
negative feedback loop to prevent further new hair follicle formation and help with 
differentiation of cells into IRS and hair shaft [94].  
WJMSCs cultured as a monolayer in OD media displayed increased mRNA levels for 
noggin at week 2 as compared to cells cultured with RM. Also, noggin levels returned to basal 
levels in both media conditions by week 4 (Figure 25B). Further, mRNA levels of noggin 
increased significantly (2 fold increase) after two weeks of 3D culture on DWJM in OD media 
and returned to basal levels by week 4 (Figure 25B). Induction of noggin mRNA levels was 
highest when WJMSCs were cultured on DWJM in the presence of OD media. The expression of 
BMP4 mRNA was almost negligible in WJMSCs cultured with or without DWJM (Data not 
shown).  
TGF-β and SMAD  
 TGF-β2 activates SMAD 2/3 in the hair follicle stem cells and lowers the level of BMP 
in the niche thereby, promoting stem cell transition from telogen to anagen [104] . In the absence 
of TGF-β2, hair follicle stem cells exhibit significant delays in hair regeneration.  TGF- β1 has 
also been proposed to play an important role in catagen regulation by inhibiting keratinocyte 
proliferation and inducing keratinocyte apoptosis [226] . Jian et al. showed that TGF-β1 induces 
rapid nuclear translocation of β-catenin in MSCs in a SMAD dependent manner.  
Hence, we evaluated the expression of SMAD2 mRNA and observed that WJMSCs cultured on 
DWJM in OD demonstrated a 2-fold increase in SMAD2 at week 2 returned to basal levels by 
week 4 as compared to WJMSCs at day 0 (Figure 25C). Similarly, the expression of TGF-β 
mRNA in WJMSCs and OD increased 0.5 fold at week 2 (Data not shown). Western blot 
analysis revealed induction of SMAD protein levels when WJMSCs were cultured as a 
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monolayer in the presence of OD as compared to RM at week 2 (Figure 26). By week 4 there 
was a sharp decline in SMAD levels suggesting tight regulation of total protein level in the cell. 
WJMSCs cultured on DWJM in both RM and OD media showed similar trend of diminishing 
expression level from week 2 to week 4. However, there was lower amount of SMAD protein 
when WJMSCs were cultured in the presence of DWJM. 
Versican  
 Versican is a proteoglycan involved in extracellular matrix assembly and cellular 
adhesion. Kishimoto et al. demonstrated that versican expression is essential for hair inductive 
properties [117]. Also, human hair follicles express versican in the dermal papilla during anagen, 
thereby suggesting its role in anagen induction and maintenance of anagen [227]. Willert et al. 
demonstrated that versican is a target of Wnt signaling through the β-catenin pathway and plays 
an essential role in maintaining dermal papilla cells in the state of anagen [228].  
WJMSCs cultured in the presence of OD media showed a strong induction of versican 
mRNA levels at week 2 (6 fold) as compared to RM (3 fold). versican mRNA levels at week 4 
were back to the basal levels, similarly, there was an up-regulation of versican mRNA levels 
when WJMSCs were cultured on DWJM in RM (8 fold) and OD media (5 fold) at week 2 and 
lowered levels at week 4 (Figure 25D). 
Exploring key factors in BMMSC-DWJM interactions 
BMMSCs cultured in both 2D and 3D conditions (on DWJM) using RM and OD media, 
displayed poor induction of β-catenin (Figure 27 A). Further, BMMSCs showed a consistent 
increase in mRNA expression level of noggin from week 2 to week 4 irrespective of the culture 
conditions. Also, BMMSCs cultured in 3D environment on DWJM in the presence of OD media 
displayed the highest induction of noggin mRNA level (90 fold) (Figure 27 B). In contrast, when 
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BMP4 was studied at the protein level, a significant protein band was found at 47KDa for all the 
samples in both the cell lines.  However, BMMSCs cultured in both 2D and 3D conditions (on 
DWJM) using RM and OD media displayed no significant change in the mRNA levels of SMAD 
(Figure 27 C) and a significant decrease in versican (Figure 27 D). 
Investigating WJMSC-dermal graft interactions  
When WJMSCs were cultured on Alloderm, a 4-fold increase in versican gene expression was 
observed when cultured in RM, while there was a 2-fold increase in OD at week 2. At week 4, 
there was a decrease in expression of versican in both the media treatments when compared to 
week 2. There was a 1-fold rise in β-catenin expression at week 2 in RM, while there were no 
variations noted in the other conditions or time points. Noggin, SMAD and TGF-β2 expression 
were significantly down regulated when WJMSCs were cultured on Alloderm. Thus no 
noteworthy differences in gene expression were noted when WJMSCs were cultured on 
Alloderm® in regular media or osteogenic differentiation media (Figure 28).  
Studying hair follicle dermal papilla induction media in our model 
When WJMSCs were cultured in 2D or on DWJM in a hair follicle dermal papilla induction 
media, there was a significant decrease noted in TGF-β, SMAD2 and β-catenin. Although there 
was a decrease in BMP4 gene expression, noggin mRNA was undetected. This potentially 







A series of interactions between the dermal mesenchyme and the epithelial-derived 
epidermis lead to skin appendages development. During hair follicle formation, the 
mesenchymal cells that form the dermal component are first visible as a cell agglomeration 
below the primary epidermal thickening [100, 157]. Our observation of cell condensations on the 
DWJM could be suggestive of similar agglomerations. Hair follicles are complex organs with the 
hair shaft made of epidermal tissues, but supported by basement membrane, dermal tissues, 
appendages and several other cells for their development, nutrition, movement, differentiation, 
growth, physical stability and coloring [229]. Reynolds and Jahoda et al. observed the expression 
of smooth muscle actin in hair follicles in situ and in hair follicle dermal cells in vitro. They 
showed that smooth muscle actin was present in the two dermal components – the dermal papilla 
and dermal sheath components of rat vibrissa, rat pelage and human hair follicles in vitro [225]. 
Morioka et al. also demonstrated that dermal sheath of skin and outer root sheath of hair follicle 
strongly stained for smooth muscle actin (SMA) [229]. Similarly, we stained DWJM seeded with 
differentiated cells and observed the cells to be positive for SMA. It was demonstrated by Stasiak 
et al. that keratin 19 distributions was observed in epidermal basal cells, in a defined region of 
the hair follicle and in the nipple epidermis [230]. Michel et al. evaluated keratin 19 as a 
biochemical marker for skin stem cells of hair follicles and demonstrated that CK19 expressing 
cells were localized in a well-defined zone of hair follicles below the sebaceous glands and bulge 
area. CK19 expression was detected throughout the phases of hair follicle cycling although the 
expression varied with hair size [224]. Similarly, we show that WJMSCs cultured on DWJM in 
OD media generated CK 19 positive cells on the edges and as cellular condensations.   
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Several researchers have demonstrated the central role of Wnt/β-catenin signaling in hair 
follicle morphogenesis and differentiation [100, 231, 232].   Van Mater et al., showed that 
Wnt/β-catenin signal in hair follicle precursor cells is an important signal for telogen-anagen 
transition [233] . Wnt signaling is also involved in patterning of skin as mice with constitutive 
overexpression of an inhibitor of Wnt signaling in skin [74] or with skin-specific deletion of β-
catenin fail to develop hair follicles [75] . Conversely mice expressing constitutively active form 
of β-catenin in their skin display new hair follicle morphogenesis in the inter-follicular 
epithelium [84]. Thus, we studied β-catenin expression in the cells seeded onto DWJM and 
observed that the cells in the area of cellular condensation and the cells on the surface of DWJM 
stained strongly positive for β-catenin, thereby favoring differentiation of hair follicles.   
My work has identified ascorbic acid 2-phosphate and vitamin D3 to be important in the 
development of hair-like structures in vitro in our model. Others have reported similar findings 
such as, Kim et al. has shown that ascorbic acid 2-phosphate, a derivative of L-ascorbic acid 
(Vitamin C), stimulates the growth of human dermal papilla cells, promotes the elongation of 
hair shafts in hair follicles in culture and induces early conversion from telogen to anagen in 
mice. They have also demonstrated that ascorbic acid 2-phosphate induces the expression of 
versican in human dermal cells, which enhances the initiation and growth of hair follicles [227, 
234]. Vegesna et al. has proved that vitamin D3 or an active form like 1, 25 di-hydroxyvitamin 
D3 has the potential to act on keratinocytes and initiate hair follicle cycling and stimulate hair 
growth in nude mice. It has also been shown that a mouse lacking the vitamin D3 receptor 
display defects leading to postnatal alopecia [235, 236]. In our model, the hair like structures 
were formed in osteogenic media without dexamethasone, while removing vitamins C, D3 or β-
glycerophosphate from culture media did not produce any hair-like structures. Thus, we believe 
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that ascorbic acid and vitamin D3 are essential components for hair follicle formation when 
WJMSCs are cultured on DWJM.  
The ectodermal differentiation potential of WJMSCs seeded on DWJM is a research area 
that has never been explored. The use of osteogenic media (OD) to culture WJMSCs while 
seeded on DWJM was initially utilized to promote osteogenic differentiation. To our surprise, 
evidence of hair type regeneration was detected. Interestingly, bone and hair regeneration follow 
similar processes like resorption by osteoclasts or catagen in hair, growth phase by osteoblasts or 
anagen and resting phase or telogen in hair. They also follow the similar molecular pathway of 
BMP-Wnt-Shh [237]. Botchkarev et al. showed that BMP4 is produced by dermal papilla 
fibroblasts and secondary germ keratinocytes and prevents onset of anagen by interactions of 
noggin. BMP2, BMP4 and BMPR-1A are expressed in epithelial and mesenchymal cells of 
developing hair bulb and in coordination with noggin, these BMPs induce anagen phase, while 
up regulating Shh[92, 216]. Shh is essential for hair follicle morphogenesis and hair cycle 
initiation. β-catenin promotes hair follicle morphogenesis and differentiation [101] while acting 
out-of phase with the BMPs [220]. In a study by Mundy et al., the peptide aldehyde proteasome 
inhibitor PSI that stimulates osteoblast differentiation and bone formation was studied in two 
separate clinical trials to treat male pattern baldness. In the phase I clinical study, 12 caucasian 
males with male pattern baldness who received the treatment showed a significant increase in 
linear hair growth, number of anagen hair, telogen hairs and anagen/telogen ratio.  In another 
double blind phase II clinical study with 50 men with androgenetic alopecia, topical application 
of this protease inhibitor showed an increase in hair density, and cumulative hair thickness 
following 8 weeks of treatment [238].  These studies supplemented with research by Aljitawi et 
al. [213], help confirm the relatedness of osteogenic differentiation to ectodermal differentiation.  
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Ultimately, different combinations of the signals may dictate the outcome of cellular 
differentiation such as – a tooth, scale, hair or feather formation [67-69]. The Wnt pathway plays 
essential role during hair follicle induction, Shh (Sonig hedgehog) is involved in late stage 
differentiation and morphogenesis, and Notch signaling determines stem cell fate and BMP is 
involved in cellular differentiation.  
To understand the molecular mechanisms behind this ectodermal differentiation and the 
formation of these hair like structures we extracted the undifferentiated and differentiated cells at 
different time points and performed molecular analysis at the transcript level and protein level 
for major key factors involved in WJMSC-DWJM interactions. We found that the up regulation 
of β-catenin, noggin, and versican during the early days of in vitro culture followed by a decrease 
in the BMP4, TGF-β and SMAD could be the primary factors in the ectodermal differentiation in 
our model. We did not find similar trends in BMMSCs cultured on DWJM or WJMSCs cultured 
in commercially available media thereby enabling us to conclude that these hair-like structures 






In this chapter, we demonstrate that WJMSCs cultured in osteogenic media on DWJM, 
differentiated into CK19 and smooth muscle actin positive cells. WJMSCs cultured on DWJM 
also produced hair-like structures reproducibly protruding from DWJM. Other MSCs like 
BMMSCs did not have the potential for such differentiation. We also explored the individual 
components of osteogenic differentiation media and showed that dexamethasone is dispensable, 
but ascorbic acid 2-phosphate, β-glycerolphosphate and 1α, 25 di-hydroxy vitamin D3 are 
essential for hair-like structure formation. We investigated well-known pathways essential for 
this differentiation and showed that the up regulation of β-catenin gene and decreased expression 
of BMP4 gene are key players in our model. β-catenin is an early signal responsible for hair 
follicle formation and is accompanied by higher expression of noggin, a BMP inhibitor. In our 
model we show that, WJMSCs cultured on DWJM in osteogenic media exhibited β-catenin 
expression and an up regulation of noggin mRNA in addition to undetectable BMP4 mRNA 
expression. On the other hand, in BMMSCs, BMP4 mRNA was detected at significant levels, 





Figure 15 – Schematic representation of the experimental design.  
WJMSCs were seeded on DWJM or DG and cultured in RM for 2 days. After 2 days they were 
grown in RM or the media was changed to OD. Samples from RM and OD media were collected 
after 2 weeks and 4 weeks and processed accordingly. The scaffolds were processed for 
histology and immunohistochemistry, the cell culture supernatant was used for ELISA and the 
cells were harvested and used for gene expression or immunoblot studies.  
WJMSCs are represented as green circles, DWJM – 7mm diameter with 2-3mm thickness, DG – 
7mm diameter with 200-500µ thicknesses. Abbreviations: WJMSCs – Wharton’s jelly 
mesenchymal stem cells, DWJM – Decellularized Wharton’s jelly matrix, DG - Alloderm dermal 
graft, RM – Regular media, OD - Osteogenic differentiation media. 







Figure 16 – Bright field microscopy images of hair-like structures according to different culture 
conditions.   
The upper panel represents WJMSCs cultured on DWJM or 2 weeks, and the lower panel 
indicates WJMSCs cultured on DWJM for 4 weeks. The white arrows point to the coiled or 
protruding hair-like structures. Figure A demonstrates the smooth surface of DWJM when 
WJMSCs were cultured on DWJM in RM, while B represents some coiled and protruding hair – 
like structures. It can also be observed that these structures were growing in size over time. Scale 







Figure 17 – Scanning electron micrograph images of hair – like structures according to different 
culture conditions.   
The top and bottom panel show Scanning electron micrographs. The image A demonstrates 
DWJM, B is WJMSCs cultured on DWJM in RM and C is WJMSCs on DWJM cultured in OD 
for 4-6 weeks. The middle and bottom row represents hair-like structures on DWJM when 
WJMSCs were cultured on DWJM in OD media. The media row and bottom row represent 
similar structures in bright field microscope and under scanning electron microscope 




Figure 18 - Confocal microscopy images of WJMSCs seeded onto DWJM and DG. 
Image A, E represent DWJM and DG respectively. Image B shows WJMSCs aligned on the 
surface of DWJM when cultured in RM, while Image D shows WJMSCs arranged randomly on 
DG in RM. Images C, D, represent WJMSCs on DWJM in OD. Image C shows hair-like 
structure made up of cells, while Image D represents cell condensations inside DWJM. G, H are 
WJMSCs cultured on DG in OD arranged in a randomly.  
Images K and I show bright field images of the hair-like structures on DWJM, while J and L 
represent confocal microscopy of the same. Calcein AM was used to stain the live cells; 





Figure 19 – Histological assessment of WJMSCs seeded onto DWJM and DG. 
When WJMSCs were cultured on DWJM in RM or OD, cells were attached and growing on the 
surface, with cellular condensation observed in some areas.  Cells were also observed growing 
inside the pores of DWJM. WJMSCs were also seen to be attached and growing on the dermal 
graft. Some cells were observed inside the matrix, while areas of cellular condensations were 




















Figure 20 – Ectodermal differentiation of WJMSCs seeded onto DWJM and DG assessed by 
immunohistochemistry.  
The scaffolds with/without cells were stained for α-smooth muscle actin (SMA), cytokeratin-19 
(CK19) and Collagen. DWJM and DG stained negative for SMA and CK19, while both the 
grafts stained highly positive for collagen (COL). WJMSCs cultured on DWJM/DG in RM/OD 








Figure 21 - β-catenin expression in WJMSCs seeded onto DWJM in RM and OD by 
immunohistochemistry.   
WJMSCs cultured on DWJM in RM did not reveal any β-catenin positive cells, while WJMSCs 
cultured on DWJM in OD stained positive for β–catenin, on the surface as well as the cellular 














Figure 22 – Assessment of hair-like structures in BMMSCs seeded onto DWJM.  
BMMSCs were cultured on DWJM in RM and OD for 2-4 weeks and the surface of DWJM 











Figure 23 – The effects of hair follicle dermal papilla conditioning media on WJMSCs seeded 
onto DWJM.  
When WJMSCs were cultured on DWJM in a hair follicle dermal papilla conditioning media, the 















Figure 24 - The effect of various components of osteogenic differentiation media on hair-like 
structure development in our model.   
To understand the components of OD responsible for the formation of hair-like structures, 
WJMSCs were cultured on DWJM in OD media by eliminating a single component every time. 
Image A, B represent WJMSCs cultured on DWJM in RM and OD respectively. Images C is 
WJMSCs on DWJM in OD without ascorbic acid (AA), Images D is WJMSCs on DWJM in OD 
without β-glycerolphosphate (BGLY), Images E is WJMSCs on DWJM in OD without 
Dexamethasone (DEX) and Images F is WJMSCs on DWJM in OD without Vitamin D3 








Figure 25 - Potential key players responsible for ectodermal differentiation in our model. Gene 
expression profiles of key genes potentially responsible for ectodermal differentiation of 
WJMSCs seeded onto DWJM according to different experimental conditions.   
The relative gene expression values for B-catenin, noggin, SMAD AND versican (VCAN) genes 
is as demonstrated.  The horizontal line represents the gene expression of WJMSCs cultured in 



















Figure 26 – Potential key proteins potentially responsible for ectodermal differentiation in our 
model.  
B-Catenin and SMAD protein levels were tested by immunoblot analysis. β – actin was used as 
the control.  Densitometry was performed with background subtraction and protein bands were 
normalized against the β-actin band of the same sample.  Values are represented as mean ± 





Figure 27 - Gene expression profile of key genes responsible for ectodermal differentiation in 
BMMSCs seeded onto DWJM.  
The relative gene expression values for β-catenin, noggin, SMAD AND versican (VCAN) genes 
is as demonstrated.  The horizontal line represents the gene expression of WJMSCs cultured in 














Figure 28 - Gene expression profile of key genes responsible for ectodermal differentiation in 
WJMSCs cultured on DG 
The relative gene expression values for B-catenin, noggin, BMP4, TGF-β2, SMAD AND 
versican (VCAN) genes is as demonstrated.  The horizontal line represents the gene expression 
of WJMSCs cultured in RM at day 0. Values are represented as mean ± Standard error (SEM) 













Figure 29 - Gene expression profile of key genes responsible for ectodermal differentiation of 
WJMSCs cultured in hair follicle dermal papilla media  
The solid bar represents WJMSCs cultured in Hair follicle dermal papilla media (HFDPM), 
while the patterned bars represent WJMSCs cultured on DWJM in HFDPM. The relative gene 
expression values for B-catenin, noggin, BMP4, TGF-β2, SMAD AND versican (VCAN) genes 
is as demonstrated.  The horizontal line represents the gene expression of WJMSCs cultured in 




Table 4 - Primers used in molecular experiments.  
 
Gene symbol Detector Gene name 
GAPDH Hs02758991_g1 Glyceraldehyde-3-phosphate dehydrogenase 
NOG Hs00271352_s1 Noggin 
BMP4 Hs03676628_s1 Bone morphogenetic protein- 4 
CTNNB1 Hs00355049_m1 Catenin (cadherin-associated protein), beta1 
TGFB2 Hs00234244 Transforming growth factor-beta 2 
SMAD2 Hs00183425_m1 SMAD family member 2 
VCAN Hs00171642_m1 Versican 
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Table 5 – Abbreviations 
 
C+M WK 2  WJMSCs cultured in 2D in regular media and sample collected at week 2 
C+OD WK 2  WJMSCs cultured in osteogenic differentiation media 2D and sample collected at 
week 2 
C+M WK 4 WJMSCs cultured in 2D in regular media and sample collected at week 4 
C+OD WK 4 WJMSCs cultured in 2D in osteogenic differentiation media and sample collected at 
week 4 
C+WJ+M WK 2  WJMSCs cultured on DWJM in regular media and sample collected at week 2 
C+WJ+OD WK2 WJMSCs cultured on DWJM in osteogenic media and sample collected at week 2 
C+WJ+M WK 4 WJMSCs cultured on DWJM in regular media and sample collected at week 4 




Chapter 4: Exploring the Potential of CK19 Positive Cells in Ectodermal Differentiation in 
vivo  
Introduction 
Wound healing is a well-orchestrated, complex process involving biological and 
molecular events such as cell migration and proliferation, extracellular matrix deposition, 
angiogenesis and remodeling [239]. In the repair and management of full thickness wounds, 
autologous grafts are considered the gold standard approach. But the limited availability and 
creation of morbidity at the donor site pose biggest challenges [21, 22]. Split thickness 
autologous graft is an alternative, but this is also associated with problems such as increased 
scarring and keloid formation [240, 241]. Therefore, tissue engineered skin grafts are a 
promising alternative for their ability to rapidly close wounds [157]. However, skin appendages 
such as hair follicles, sebaceous glands and sweat glands cannot be restored due to their limited 
self-regeneration abilities [242] . 
Thus, several novel mesenchymal stem cells based therapies for skin regeneration and 
repair are being developed with the potential to regenerate skin with its associated appendages 
[243-247]. Stem cell aggregates from rat bone marrow MSCs (BMMSCs) were applied to rat 
cutaneous wound and showed that the aggregates presented better neo-vascularization and 
collagen deposition compared to intravenous or topical application [248]. Doi et al. injected two 
kinds of MSCs, one obtained from human umbilical cord blood (UCBMSCs) and the other from 
Wharton’s jelly (WJMSCs) on a 5 mm full thickness skin defect in nude mice and showed that 
the umbilical cord blood derived MSCs are a favorable potential stem cell source for wound 
healing with less scarred tissue formation [243]. Luo et al. used UCBMSCs on cutaneous skin 
wounds and showed enhanced healing and keratinocyte differentiation at the wound site [249]. 
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Mesenchymal stem cells obtained from Wharton’s jelly of the human umbilical cord are, easily 
accessible, noncontroversial, and multipotent with ability of differentiating into bone, cartilage, 
muscle, adipose and neural cells [128]. Sabapathy et al. seeded WJMSCs on a decellularized 
amniotic membrane scaffold and transplanted on a mice model to demonstrate that this 
combination aids in reduced scar formation with hair growth and improved biomechanical 
properties [244]. Pratheesh et al. isolated caprine WJMSCs and transplanted on a full thickness 
skin wound in a rabbit model to show that these MSCs had better epithelialization and collagen 
deposition compared to the controls [245]. Arno et al. used human WJMSCs conditioned media 
on normal skin fibroblasts and proved that WJMSCs promote skin wound healing through 
paracrine signaling [246].  It was established by Azari et al. that, when WJMSCs from a goat 
were transplanted on a 3 cm full thickness wound on goat, there was less inflammation, thinner 
granulation tissue with minimum scar formation compared to the controls with no MSCs [247]. 
Therefore, in this study, Decellularized Wharton’s jelly Matrix (DWJM) with previously 
generated CK19 positive cells and hair like structures [213] are transplanted onto a full thickness 
wound on the back of a mice and evaluated for their wound healing and skin regeneration 
potential. An Alloderm® regenerative tissue matrix (Life Cell Inc.) was used to cover the 
wounds and keep the tissues hydrated. Alloderm dermal graft (DG) is an acellular human dermal 
tissue matrix that integrates into the patient’s tissue and promotes repair with rapid 
revascularization and white cell migration [250]. It is easy to handle and has remarkable ability 
to form functional tissue that provide structural support. This dermal graft has been used in many 
soft tissue reconstructions like abdominal wall reconstruction, breast reconstruction, and head 
and neck plastic reconstruction [251]. Achauer et al. used this Alloderm dermal graft in 11 
patients with soft tissue defects or scarring on the face. They showed that dermal graft acts as an 
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excellent augmentation material for soft tissue defects with no rejections, mobilization, 
absorption, dislocation or extrusion associated with other materials [252]. Alloderm can act as a 
substitute to minimize problems associated with donor site morbidity and lack of adequate tissue 
for reconstruction [252].  
WJMSCs were seeded onto DWJM, DG, and DWJM+DG and cultured in vitro using 
osteogenic differentiation media (OD) or regular media for 4 weeks. The differentiated WJMSCs 
along with the matrix were transplanted onto a 1.5cm X 1.5cm wound on the back of C57BL/6J 
mice and studied for its wound healing capabilities. It was observed that mice transplanted with 
DG and differentiated WJMSCs demonstrated superior wound healing and hair growth compared 
to controls. Mice with DG+DWJM and differentiated WJMSCs also exhibited complete skin 





Materials and Methods  
Human umbilical cord collection, WJMSCs and WJ tissue harvest followed by 
decellularization were performed according to the IRB protocol # HSC 12129 of the university 
of Kansas Medical Center. Umbilical cords were collected from consented donor mothers with 
full-term pregnancy immediately after normal vaginal delivery. The umbilical cord was placed in 
a transport solution made of Lactated Ringer’s solution supplemented with penicillin 800 U/ml 
(Sigma-Aldrich, St. Louis, MO), streptomycin 9.1 mg/ml (Sigma-Aldrich), and amphotericin 
0.25 mg/ml (Sigma-Aldrich) and immediately refrigerated at 4°C. The decellularization process 
was initiated within 72 hours of umbilical cord collection.  
 Decellularization process 
The decellularization procedure was carried out as described in our earlier publication 
[169]. Briefly, umbilical cords were dissected and subjected to two cycles of osmotic shock, by 
alternating with a hypertonic salt solution containing sodium chloride, mannitol, magnesium 
chloride, and KCl. The tissues were further subjected to an anionic detergent (Sodium lauryl) 
and, sodium succinate (Sigma L5777), alternating with a recombinant nucleic acid enzyme, 
(Benzonase™) in buffered (Tris Hcl) water for 16 hours.  Following this, an organic solvent 
extraction was done and all of the detergent and other processing residuals were then removed 
utilizing ion exchange beads. The decellularized matrix was cryopreserved using 10% human 
recombinant albumin (Novozymes) and 10% DMSO (Sigma) solution in standard RPMI media, 
employing a material specific computer controlled freezing profile that was developed to freeze 




 Isolation, expansion, and MSCs seeding onto DWJM 
 Preparation of DWJM for seeding with MSCs 
Freshly obtained fragments of DWJM were transferred to a large petri dish and covered 
with phosphate buffered saline (PBS). DWJM pieces (5-7mm in diameter) were obtained using a 
sterile 5-7 mm skin punch biopsy kit or 1.5 X 1.5 cm pieces were obtained by cutting the matrix 
into square pieces.  
 Preparation of Dermal graft for cell seeding  
The Alloderm® dermal grafts were purchased from Life cell Inc. (Bridgewater, NJ) and 
cut into 1 X 1 cm or 1.5 X 1.5 cm scaffolds of 150-250µ in thickness. These scaffolds were 
soaked in sterile PBS solution before use for rehydration.  
The control DWJM / dermal graft scaffolds were washed twice in PBS and pre-incubated 
in low glucose DMEM (Sigma-Aldrich) with 10% FBS (Atlanta Biologics) and 1% 
Penicillin/streptomycin (Sigma-Aldrich) for 24 hours at 37°C, 5% CO2 and 90% relative 
humidity. After incubation, the scaffolds were washed multiple times in PBS to remove the 
media before transplantation in the mice. 
 MSC isolation and expansion 
WJMSCs were isolated and expanded according to the procedures described by Wang et 
al. [171]. Briefly, the outer layer of the cord was carefully removed and the cord was cut into 
smaller segments. The blood vessels were dissected from these cord segments and then cut into 
smaller pieces and digested with Collagenases (Worthington Biochemical Corporation, 
Lakewood, NJ) in low glucose DMEM (Sigma-Aldrich, St. Louis, MO) with 10% FBS (Atlanta 
Biologics, Atlanta, GA) and 1% Penicillin/Streptomycin (Sigma-Aldrich, St. Louis, MO) 
overnight at 37°C to obtain WJMSCs. The WJMSCs were passaged and maintained in low 
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glucose DMEM with 10% FBS and 1% Penicillin/Streptomycin. WJMSCs from passages 2 - 5 
were used for the experiments. 
Labeling of WJMSCs with Indocyanine green 
The undifferentiated WJMSCs were labeled with Indocyanine green (MP Biomedicals, 
Santa Anna, CA) before injecting into the mice wound. Indocyanine green is a negatively 
charged polymethine dye that forms non-covalent fluorescent complex with proteins. This FDA 
approved dye with psuedofluorogenic property has been used for clinical applications such as 
cancer treatments, reconstructive surgeries, coronary and retinal surgeries and angiography 
[253]. Previous studies demonstrated that a concentration greater than 0.5mg/ml was cytotoxic to 
the cells [254, 255]; hence a concentration of 0.2 mg/ml was used for these studies, as suggested 
by Sabapathy et al. [244]. WJMSCs were incubated with 0.2-mg/ml indocyanine green for 1 
hour, washed twice with PBS and immediately injected around the mice wounds.  
MSC seeding onto scaffolds  
For each set of seeding experiments, single-donor (n=1) WJMSCs was used. Briefly 1 x 
106 MSCs were suspended in 100-µl culture medium and seeded on each DWJM scaffold/dermal 
graft scaffold (average seeding density was 1.4 X 104  - 4 x 104/mm3 DWJM scaffold) in a 24-
well non- tissue culture treated plate. 1 ml of medium/well was added to the cells on the 
scaffolds. After 2 days, the media was changed to osteogenic differentiation media (OD) which 
is composed of regular media with 100 nM dexamethasone (Sigma-Aldrich, St. Louis, MO), 
5mM β-glycerophosphate (Sigma-Aldrich, St. Louis, MO), 10nM 1α 25 di-hydroxy vitamin D3 
(Enzo life sciences, Farmingdale, NY), 50 µg/ml ascorbic acid 2-phoshate (Sigma-Aldrich, St. 




Animal surgeries  
All animal experiments were performed according to the University of Kansas Medical 
Center IACUC protocol # 2014.2192. 4 - 8 week old C57BL/6J mice were purchased from 
Jackson Laboratories. Mice were anesthetized with intraperitoneal injection (IP) of ketamine (90-
150 mg/kg) (Vedco) and xylazine (7.5-16 mg/kg) or Isoflourane gas. Buprenorphine SR (0.15-
0.5 mg/kg) (Zoopharm pharmacy) was given intraperitoneally pre-op. The back of the mice was 
shaved after applying a commercially available hair removal cream (Nair, Ewing, NJ).  
Study I  
For the first study, 10 C57BL/6J mice were employed and a 1 X 1 cm full thickness 
excisional wound was made on the back of the mice. The wound was transplanted with 7 mm 
diameter DWJM seeded with differentiated WJMSCs and covered with a DG (test)(n = 5) or left 
empty and covered with a DG (control)(n = 5). The graft material was sutured to the adherent 
skin.  
Study II 
In the second set of experiments, 50 C57BL/6J mice were used and 1.5 X 1.5 cm full 
thickness excisional skin wound was carefully made on the back of the mice. The defect was 
transplanted with grafts (DG/DWJM) of 1.5 X 1.5 cm dimensions, (Test) (n=5) or left covered 
with a tegaderm dressing (Control) (n = 5). Surgical wound clips were used to attach the graft to 
skin. Tegaderm transparent dressing (Nexcare, St.Paul, MN) was used to cover the wounds and 
keep the grafts hydrated. Mastisol liquid adhesive (Ferndale laboratories, MI) firmly attached the 
tegaderm in place. The mice were divided in 10 groups of n = 5, monitored for 2 weeks and 




1. Wound alone  
2. Dermal graft alone 
3. DWJM alone 
4. DWJM+DG alone  
5. DWJM with undifferentiated cells  
6. DG with undifferentiated cells 
7. DWJM+DG with undifferentiated cells 
8. DWJM with differentiated cells  
9. DG with differentiated cells  
10. DWJM+DG with differentiated cells  
 
Mice with wound-alone received 1.5 X 1.5 cm full thickness excisional skin wound that was 
covered with tegaderm transparent dressing and served as our controls. The mice with DG or 
DWJM or DG + DWJM received 1.5 X 1.5 cm defect, which was transplanted with the 
respective graft material and closed with wound clips. Experimental groups with undifferentiated 
cells comprised of 1X106 WJMSCs in 1 ml PBS labeled with indocyanine green and injected at 
the corners of the defect at the time of surgery. Groups with differentiated WJMSCs had 1 X 106 
WJMSCs seeded on the scaffolds and cultured in regular media for 2 days, followed by media 
with osteogenic components for 4 weeks. These scaffolds were then used for transplantation in 
mice (Figure 30).  
IVIS Imaging  
Mice with indocyanine green were imaged using IVIS imaging station (PerkinEmler) on 
day 1, 4, 7 and 14. Mice were anaesthetized with isofluorane gas prior to imaging. The animals 
Control 
Undifferentiated WJMSCs  
Differentiated WJMSCs  
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were euthanized after imaging according to the protocol and the newly regenerated skin sample 
with the adjoining tissue were collected after 2 weeks in 10% phosphate buffered formalin 
(Newcomen supply) for 24 hours. 
Histology and Immunohistochemistry  
The skin sections were fixed in 10% formalin embedded in paraffin, sectioned, and 
stained with H&E. The tissues were also stained with trichrome stain kit – Richard Allan 87020 
(Thermo Fisher, Waltham, MA). Staining was performed as per the manufacturer’s instructions. 
Using this stain, the nuclei were stained bluish-black to black; cytoplasm, muscle fibers and 
keratin stained red, while collagen and mucus stained blue. Slides were reviewed using Olympus 
BX40 microscope and pictures were acquired using DP72 digital camera.  
Immunohistochemistry staining was performed using IntelliPATH FLX™ automated 
stainer (Biocare Medical, Concord, CA) at room temperature. Briefly, after deparaffinization and 
rehydration, the tissues were incubated with primary antibodies against CYTOKERATIN 19 
(1:50 dilution; Biocare Medical, Concord, CA), HLA class 1 ABC (1:400 dilution, Abcam, 
Cambridge, MA), Mitochondria Ab-2 (1:100 dilution, Lab Vision, Fremont, CA) for 30 minutes 
at room temperature. After rinsing, the section was incubated with anti-mouse HRP-labeled 
polymer (EnVision™ + system, Dako, Carpinteria, CA). Finally, the staining was visualized by 
DAB (Dako, Carpinteria, CA) and nuclei were counterstained with hematoxylin.  
Quantification of hair follicles and sebaceous glands 
 All tissue sections were observed under the microscope (10X) and the total numbers of 
newly generated appendages (hair follicles and sebaceous glands, evaluated separately) were 
counted between the wound edges. These numbers are reported as the total number of 
appendages in Table 9 (5 mice per group were evaluated.) To estimate the density of new hair 
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follicles and sebaceous glands, the appendages were counted in a 600 X 800µ area of each 
histological section. The average density of appendages in each mouse was calculated by 
examining 3 independent wound areas.  For each group 5 mice were evaluated and their average 
was calculated and reported in Figure 39. 
Statistical analysis 
All data is expressed as means ± standard error of mean (SEM) and analyzed using, 
student’s t-test, two-way analysis of variance (ANOVA) with Bonferroni post-test. A threshold 
of p ≤ 0.05 determined statistical significance. The statistical analyses were performed utilizing 




Development of acellular structures at the interface of DWJM and DG  
In the first experiment, the differentiated WJMSCs on DWJM were transplanted onto a 1 
X 1 cm full-thickness excisional skin wound on C57BL/6J mice and wound healing was studied 
for 7 days. The dermal graft and DWJM with differentiated cells were implanted as shown in the 
figure (Figure 30). The matrix was placed inside the wound and a dermal graft was used to cover 
the wound and protect DWJM from dehydration. In the control group the wounds were covered 
with only dermal graft (Figure 30). After 7 days, there was no significant change observed in the 
extent of wound healing between the control and test (Figure 31). The wounds healed to similar 
extent and the dermal graft was detectable in both groups (Figure 32A, C), although, the group 
with DWJM and differentiated cells demonstrated acellular structures at the interface of DWJM 
and DG (Figure 32C, E). These structures looked morphologically similar to the cross-sections 
of hair follicles leading us to speculate that these may be rudimentary hair like structures. Some 
anti-human mitochondrial antibody positive cells surrounded these structures as observed by 
immunohistochemistry suggesting the cells of human origin with ectodermal potential might be 
producing these hair-like structures (Figure 32F). These structures also resembled the vibrissae 
follicle-like structures demonstrated by Morioka et al. [229], although SMA positive cells were 
not observed around them. Areas of cell condensations were also observed below these 
structures, suggesting possible ectodermal differentiation to form hair follicles. Areas of cell 
condensations were observed near DWJM (Figure 32E), suggesting that DWJM might be acting 
as a potential mesenchymal surface and dermal graft acting as an epithelial surface, leading to 
potential epithelial-mesenchymal interactions.  
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Since there was no difference in wound healing rates between the test and control groups 
(Figure 31), we performed another experiment with an increased size of the wound and assessed 
wound healing for extended duration of 2 weeks.  
Transplanting dermal graft seeded with differentiated WJMSCs enhances wound healing 
and hair growth 
Wound assessment 
Full thickness excisional skin wounds measuring 1.5 x 1.5 cm were performed on the 
back of 50 C57BL/6J mice that were divided into 10 groups (n = 5) and monitored for 14 days as 
described in Figure 33. After 14 days of healing wound dimensions were measured and the 
healing rate was calculated as follows –  
𝐻𝑒𝑎𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑒 = 1−
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑡ℎ𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙 𝑤𝑜𝑢𝑛𝑑
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑤𝑜𝑢𝑛𝑑 𝑋 100% 
. The mice with DWJM and differentiated cells showed 97.64% healing and mice with 
DWJM and undifferentiated cells had 79.04% wound healing, while mice with DWJM only 
demonstrated 92.39% healing (Figure 37). In DWJM with undifferentiated cells, the WJ matrix 
was found attached to the wound and the matrix prevented the wound contraction in 2 mice. It 
was interesting to note that the mice with DWJM did not demonstrate any hair regeneration at 
the wound site. It was observed that mice with DG and differentiated WJMSCs demonstrated the 
maximum wound healing of 98.71% along with fully regenerated hair at the wound site. 
Although DG with undifferentiated cells and DG alone groups achieved 94.4 % and 97.86% 
healing respectively, these groups did not regenerate hair (Figure 35). The mice group that 
received both DG+DWJM demonstrated 96.73% healing with differentiated cells, 87.75% with 
undifferentiated cells and only 47.61 % healing without any cells (Figure 36). Also, it was 
noticed that mice transplanted with DWJM alone, showed the least wound contraction while 
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mice groups with wound alone also exhibited good wound healing without any hair growth 
(Figure 37, Figure 38, Figure 39). 
Understanding the fate of transplanted undifferentiated WJMSCs 
WJMSCs were cultured in regular media, labeled with indocyanine green and injected 
around the wound site before transplantation with the graft material (DG, DWJM, DG+DWJM). 
After transplantation, mice with labeled WJMSCs were imaged using IVIS imager and it was 
observed that on day 1, the green fluorescence signal was restricted to the wound surroundings. 
On day 4, fluorescence was observed in the area of the DG and DWJM indicating possible 
cellular infiltration into the grafts although no fluorescence was detected on the graft for mice 
with both DG and DWJM (Figure 40, Figure 41, Figure 42). But it was interesting to note that 
mice with DG and DWJM also demonstrated some fluorescence in the area of the grafts by day 
14, suggesting delayed cellular infiltration into the wound site (Figure 42). The fluorescence 
intensity also decreased with time suggesting dilution of fluorescence signal due to WJMSCs 
proliferation or cell death.  
Histopathological observations  
After 14 days, DG group seeded with differentiated cells appeared to have completely 
healed with epithelialization and appearance of skin associated appendages. In the group with no 
intervention to the wound, we noticed incomplete epithelialization indicting that the wounds 
primarily healed by wound contraction (Figure 46, Figure 50). All the mice revealed blue 
collagen deposition using trichrome staining.  
DWJM  
  Mice with DWJM demonstrated collagen deposition at the newly generated tissue in the 
wound bed but no new epidermis or appendage formation was observed (Figure 43). A hyper 
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proliferative epithelium was noticed at the wound corners. On the contrary, in the group of mice 
with DWJM and differentiated WJMSCs, the matrix was undetectable with an incomplete and 
hyper proliferative epithelium at the wound corners. In the mice group with DWJM alone, 
evidence of epithelialization was noticed at the wound edges only. Also, epithelial cells appeared 
to form below DWJM, and cellular infiltration was observed at the bottom layers of DWJM in 
contact with wound bed, while almost no cells were observed towards the exposed area. 
Immunohistochemistry revealed some cells in the wound bed of mice with DWJM and 
differentiated WJMSCs were stained positive for CK19 and human mitochondrial protein while, 
the mice wounds with DWJM and undifferentiated WJMSCs were only positive for CK19 
(Figure 47). The mice with DWJM alone did not reveal any cells, which were of human origin or 
CK19 positive.  
Dermal graft  
 The mice with DG showed 98%±2.8% wound healing grossly, and histologically 
demonstrated epithelialization (multi-layered epidermis regeneration) at the wound site, although 
no skin appendages were observed (Figure 44). The group transplanted with DG and 
undifferentiated cells revealed some epithelialization without any new appendage regeneration. 
However, the group with DG and differentiated cells achieved almost complete epithelialization 
with near total growth of hair and the associated appendages such as sebaceous glands. 
Histologically, there was continuous epithelialization with the associated skin appendages. 
Immunohistochemistry identified cells which are positive for CK19 and human mitochondrial 
protein in both the groups with DG + differentiated/undifferentiated WJMSCs, while no such 




In this group, wounds were transplanted with DWJM and covered with dermal graft. 
DWJM was in direct contact with the wound and acted as a barrier between DG and the wound. 
When both the grafts were transplanted onto the wound site discontinuous epithelialization was 
observed. In mice with DG+DWJM and WJMSCs injected around the wound, the epidermal 
layer from the wound edges appeared to be growing below the DWJM at the ends of the graft, 
but this was also discontinuous.  Finally, in mice with DG+DWJM and differentiated WJMSCs, 
the grafts were undetectable, while, complete epithelialization with skin appendages were 
observed (Figure 45). The immunohistochemistry were similar to the observations in the mice 
groups with DWJM, as mice with DG+DWJM and differentiated WJMSCs demonstrated CK19 
and human mitochondrial positive staining, while in the case of DG+DWJM with 
undifferentiated cells, it only showed some cells positive for human mitochondria. Mice with 
DG+DWJM without any cells did not reveal any cells of human origin or CK19 positivity 
(Figure 49).  
Quantification of the newly regenerated appendages  
 Wound areas were carefully evaluated for hair follicle and sebaceous gland 
formation. Mice groups with wound alone, grafts alone (DG/DWJM/DG+DWJM), and grafts 
with undifferentiated WJMSCs did not generate any new appendages. Mice with DG and 
differentiated WJMSCs and DG+DWJM with differentiated WJMSCs generated hair follicles 
and sebaceous glands at the wound site. However, mice with DWJM and differentiated WJMSCs 
did not show any appendage development. The total number of appendages were counted at the 
wound site and reported as in Table 9. The density of the hair appendages was calculated as 
described above and it was observed that the native skin of the mice had the 25 hair follicles and 
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9 sebaceous glands on average in a 600 X 800µ area examined under the microscope (10X). For 
our discussion the density of hair follicles or sebaceous glands will be referred to as the number 
of hair follicles or sebaceous glands per defined area.  Mice group with DG and differentiated 
WJMSCs demonstrated approximately 17 new hair follicles and 7 sebaceous glands in 600 X 
800µ area at the wound site, while the mice group with DG+DWJM and differentiated WJMSCs 
showed 10 new hair follicles and 4 sebaceous glands in a 600 X 800µ area (Figure 39). These 
results in combination with the other immunohistochemical observations suggest that the 
differentiated WJMSCs on DG and DG+DWJM have the potential to regenerate skin with all the 







Ectoderm is one of the three primary germ layers in the early embryo that differentiates 
into epidermis, parts of nervous system such as spine, peripheral nerves, and brain and exocrine 
glands such as mammary, sweat, salivary and lacrimal glands [212]. WJMSCs are multipotent, 
non-controversial source of stem cells, which can be obtained easily and are self-renewable, 
proliferative with immunosuppressive properties [128, 256]. WJMSCs are known to differentiate 
into cells of different lineages such as bone, cartilage and fat, upon exposure to appropriate 
stimuli [244, 256]. There has been an increasing research interest in the application of WJMSCs 
in wound healing and skin regeneration applications since it has been well established that MSCs 
produce a variety of proteins, cytokines and adhesion molecules that regulate aspects of 
hematopoiesis [243, 247]. MSCs are also known to alter tissue microenvironment and promote 
tissue repair by secretion of factors that enhance regeneration of injured cells by stimulating 
proliferation and differentiation and decreasing inflammatory and immune reactions [247, 257, 
258].  It has been demonstrated from the proteomic analysis of MSC conditioned medium that 
MSCs secrete many known mediators of tissue repair including growth factors like vascular 
endothelial growth factor (VEGF), monocyte chemo-attractant protein-1 (MCP-1) and 
hepatocyte growth factor (HGF). These growth factors were reported to stimulate fibroblast 
proliferation, aid during the inflammatory response of wound healing and accelerate 
angiogenesis [258].  
Liu et al. demonstrated that human WJMSCs did not express MHC-II and co-stimulatory 
molecules such as CD 40, CD 80 and CD 86, but moderately express MHC-I. They exhibited 
immune inhibitors such as HLA-G, IDO, PGE2 thereby demonstrating low immunogenicity and 
potential to induce to induce immune tolerance microenvironments in hosts [259].  While, 
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several researchers have demonstrated the role of undifferentiated WJMSCs in wound healing, 
we found that osteogenic differentiated WJMSCs resulted in superior results in our model. Arno 
et al. showed that WJMSCs promote skin wound healing by promoting paracrine signaling. 
When adult human skin fibroblasts were treated with WJMSC conditioned media they showed 
enhanced fibroblast migration, proliferation and promoted wound healing in mice [246]. It has 
also been demonstrated that paracrine signaling from MSCS promotes angiogenesis, 
immunomodulation and recruitment and differentiation of endogenous tissue stem/progenitor 
cells, thus encouraging wound healing [259, 260]. 
 Thus, in this dissertation we explored the role of WJMSCs in ectodermal differentiation 
applications such as wound repair and skin regeneration. This was studied by two methods – by 
transplanting undifferentiated WJMSCs at the wound site or by transplanting the scaffolds with 
differentiated WJMSCs at the wound site. The cellular migration in cutaneous wound healing 
was studied by labeling the cells with indocyanine green. We demonstrate that WJMSCs can be 
successfully transplanted at the wound site and the WJMSCs infiltrated the graft (DG/DWJM) by 
labeling the cells with non-toxic, non-ionizing indocyanine green and studying fluorescence. 
Thus undifferentiated WJMSCs labeled with indocyanine green, were used to track WJMSCs 
injected at the wound site. Cellular infiltration was observed in both the graft materials, although 
the fluorescence intensity was reduced with time suggesting cellular division or cell death.   
Herein, we show that WJMSCs could be successfully seeded on the graft materials and 
cultured in vitro and transplanted in vivo. In the mice with DWJM, there was hyper proliferative 
epithelium at the wound corners, which was interrupted. This could have resulted from the 
thickness of the DWJM (2-3mm) as opposed to the DG (250-500µ) which might have limited the 
availability of nutrients necessary for cellular proliferate and growth. The thickness of DWJM 
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might have also resulted in the drying of graft on the exposed surface. On the contrary, mice with 
dermal graft alone produced a continuous epidermis, although no skin appendages were 
observed. 
The dermal graft seeded with WJMSCs and differentiated in vitro for 4 weeks followed 
by transplantation on mice wounds demonstrated the best healing and complete regeneration of 
skin with its associate structures such as hair follicles and sebaceous glands. The newly 
regenerated tissue also demonstrated some cells of human origin along with CK19 positive cells 
indicating these cells might have migrated from the graft. Although dermal graft alone also 
showed complete wound healing, hair follicles and sebaceous glands were undetected. Mice with 
DG and undifferentiated cells exhibited a proliferative epithelium and epithelialization at the 
wound edges, but failed to produce a continuous epithelium, thus suggesting that the 
differentiated cells play a key role in the development of skin appendages. 
Immunohistochemistry also identified some cells positive for human mitochondrial protein 
suggesting that the undifferentiated WJMSCs might have played some role in wound healing. 
Although mice with DWJM and differentiated cells alone did not aid in wound healing, 
the DG+DWJM mice with differentiated cells demonstrated continuous epithelium. There was 
complete skin regeneration at the wound edges, but delayed in the center of the wound, 
signifying it was taking longer for the appendages to form compared to DG with differentiated 
cells alone. DG+DWJM with or without WJMSCs demonstrated hyper proliferative epithelium 
at the wound edges, intact DWJM matrix, which interrupted the growth of a continuous 
epithelium. Thus, DG was necessary to keep the DWJM matrix hydrated and support wound 
healing process. Undifferentiated WJMSCs on DWJM/DG/DWJM+DG showed a hyper 
proliferative epithelium at the wound edges.  Mice groups with DG, DG+DWJM and 
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differentiated cells demonstrated almost complete epithelialization and appendage development 
although; very few cells of human origin were identified at the wound site. Thus, we believe that 
the differentiated cells played a key role in skin appendage development in this group too, 
thereby supporting our hypothesis that the WJMSCs differentiated in OD might be having a 
paracrine effect in promoting epithelial growth while playing a structural role in producing a 
continuous epidermis to help in wound healing.  Further work needs to be performed to assess 
the role of undifferentiated WJMSCs in our model and optimizing DWJM thickness to aid in 






WJMSCs differentiated using DWJM and OD and undifferentiated were successfully 
transplanted onto the wound site and exhibited differential wound healing results. WJMSCs 
infiltrated the graft materials and WJMSCs were detected at the wound site for 14 days.  Dermal 
grafts with differentiated WJMSCs demonstrated superior reconstitution of dermis, allowed re-
epithelialization of wounds along with the development of the associated skin appendages such 
as hair follicles. While the use of DWJM with differentiated WJMSCs in the wound bed without 
dermal graft did not promote complete wound healing, the addition of DG to DWJM with 
differentiated cells showed reconstitution of dermis and re-epithelialization of wounds, with 
some degree of appendage development. Thus, the presence of dermal grafts seeded with 
differentiated WJMSCs was essential for promoting complete wound healing, while the presence 
of DWJM at the wound bed might have negative effects on appendage development. Hence, 







Figure 30 – Wound-healing study experimental design.  
Image A shows mice with a 1 X 1 cm full thickness excisional wound. In this image, the green 
arrow points to DWJM, red arrow denotes the exposed wound area and yellow arrow shows DG 
during the surgery. Image B shows the wound after DG has been sutured and Image C shows the 














Figure 31 –Wound-healing assessment.  
 
The control mice had DG alone, while the test group had mice with DWJM with differentiated 
cells and the wound was closed with DG. There was no significant difference noticed between 






























Figure 32 - Histological assessment of the wound bed across various groups. 
 
Image A, B represents the wound with DG alone, while Images C-F show wound with DG and 
DWJM transplanted with differentiated WJMSCs.  The black arrows in Image A and C denote 
the wound edges. The red box in Image C shows the acellular structures with cellular 
condensation below them. The red box is imaged at a higher resolution in Image E, and the blue 
circles on image E show the acellular structures. Image F demonstrates the 
immunohistochemical staining of the tissues with human mitochondrial protein.  The arrows in 
Image F point to cells positive for human antibody. The scale bars in 4X represent 200µ, 20X is 





Figure 33 - Schematic representation of the experimental design of wound healing animal study.  
 
The grafts were transplanted at the wound sites in controls. WJMSCs labeled with Indocyanine 
green (ICG) were injected at the wound site for imaging using IVIS imager. In the last group, 
WJMSCs were cultured on the grafts in vitro for 4 weeks as shown above and later transplanted 
onto full thickness wounds on mice.  
DWJM – Decellularized Wharton’s jelly matrix, DG- Alloderm dermal graft, OD – osteogenic 






Figure 34 -Wound-healing assessment by gross appearance in mice groups with DWJM 
Representative gross morphological images of all the experimental and control groups. They are 
divided into categories based on the type of graft. The mice wounds almost healed in most of the 
groups and hair regeneration was observed in groups with DG and differentiated cells and 




Figure 35 -Wound-healing assessment by gross appearance in mice groups with DG.  
Representative gross morphological images of all the experimental and control groups. They are 
divided into categories based on the type of graft. The mice wounds almost healed in most of the 
groups and hair regeneration was observed in groups with DG and differentiated cells and 




Figure 36 - Wound-healing assessment by gross appearance in mice groups with DG+DWJM.  
Representative gross morphological images of all the experimental and control groups. They are 
divided into categories based on the type of graft. The mice wounds almost healed in most of the 
groups and hair regeneration was observed in groups with DG and differentiated cells and 






Figure 37 – Wound-healing assessment by gross appearance in mice with wound alone. 
Representative gross morphological images of all the experimental and control groups. They are 
divided into categories based on the type of graft. The mice wounds almost healed in most of the 
groups and hair regeneration was observed in groups with DG and differentiated cells and 






Figure 38 – Qualitative and quantitative assessment of wound healing by microscopy among 
various experimental conditions.  




























































Figure 39 –Quantitative assessment of appendage development by microscopy among various 
experimental conditions.   
The appendages were counted in a 600 X 800µ area of the newly regenerated skin. (* Indicates 
p<0.05). The other groups tested did not show any appendage development, hence are not shown 


























































































Figure 40 - Tracking the fate of transplanted WJMSCs in mice with DWJM using in vivo 
imaging.   
The undifferentiated WJMSCs were labeled with indocyanine green prior to transplantation. 
Thus, green fluorescence was observed around the wound sites at day 1, while there was 
fluorescence on the graft material at day 4. The intensity of fluorescence decreased with time 





Figure 41 - Tracking the fate of transplanted WJMSCs in mice with DG using in vivo imaging. 
   
The undifferentiated WJMSCs were labeled with Indocyanine green prior to transplantation. 
Thus, green fluorescence was observed around the wound sites at day 1, while there was 
fluorescence on the graft material at day 4. The intensity of fluorescence decreased with time 




Figure 42 - Tracking the fate of transplanted WJMSCs in mice with DG+ DWJM using in vivo 
imaging.   
The undifferentiated WJMSCs were labeled with indocyanine green prior to transplantation. 
Thus, green fluorescence was observed around the wound sites at day 1, while there was 
fluorescence on the graft material at day 4. The intensity of fluorescence decreased with time 





Figure 43 -Histological assessment of wound healing in mice groups with DWJM  
Images A, C, E, G, I, K are tissue sections stained in H&E, with A, C and E are 4X 
magnification, while G, I and K are images at 20 X magnification. Images B, D, F, H, J, L are 
tissue sections in trichrome staining. Blue color represents collagen deposition, red is for keratin, 
cytoplasm is in light pink to red, and nuclei are in blue/black. The arrows in the images show the 












Figure 44 – Histological assessment of wound healing in mice groups with DG 
 
Images A, C, E, G, I, K are tissue sections stained in H&E, with A, C and E are 4X 
magnification, while G, I and K are images at 20 X magnification. Images B, D, F, H, J, L are 
tissue sections in trichrome staining. Blue color represents collagen deposition, red is for keratin, 
cytoplasm is in light pink to red, and nuclei are in blue/black. The arrows in the images show the 





Figure 45 -Histological assessment of wound healing in mice groups with DG+DWJM  
 
Images A, C, E, G, I, K are tissue sections stained in H&E, with A, C and E are 4X 
magnification, while G, I and K are images at 20 X magnification. Images B, D, F, H, J, L are 
tissue sections in trichrome staining. Blue color represents collagen deposition, red is for keratin, 
cytoplasm is in light pink to red, and nuclei are in blue/black. The arrows in the images show the 


























Figure 46 -Histological assessment of wound healing in mice with wound alone  
Images A, C, E, G, I, K are tissue sections stained in H&E, with A, C and E are 4X 
magnification, while G, I and K are images at 20 X magnification. Images B, D, F, H, J, L are 
tissue sections in trichrome staining. Blue color represents collagen deposition, red is for keratin, 
cytoplasm is in light pink to red, and nuclei are in blue/black. The arrows in the images show the 








Figure 47 -Wound-healing assessment by immunohistochemistry in mice groups with DWJM 
 
The tissue sections are stained with antibodies against Cytokeratin 19 and human mitochondrial 
protein. The positive cells are detected in brown. The black arrows represent cells positive CK19 






Figure 48 -Wound-healing assessment by immunohistochemistry in mice groups with DG  
 
The tissue sections are stained with antibodies against Cytokeratin 19 and human mitochondrial 
protein. The positive cells are detected in brown. The black arrows represent cells positive CK19 





Figure 49 -Wound-healing assessment by immunohistochemistry in mice groups with DG + 
DWJM  
 
The tissue sections are stained with antibodies against Cytokeratin 19 and human mitochondrial 
protein. The positive cells are detected in brown. The black arrows represent cells positive CK19 






Figure 50 – Wound-healing assessment by immunohistochemistry in mice with wound alone 
 
The tissue sections are stained with antibodies against Cytokeratin 19 and human mitochondrial 
protein. The positive cells are detected in brown. The black arrows represent cells positive CK19 
and the red arrows indicate cells positive for mitochondrial staining.  
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Group Cell type Indocyanine green 
451-455 DG+Diff WJMSCs Differentiated WJMSCs Absent 
456-460 DWJM+Diff 
WJMSCs 
Differentiated WJMSCS Absent 
461-465 DG+DWJM+Diff 
WJMSCs 
Differentiated WJMSCs Absent 
486-490 DG+ WJMSCs WJMSCs Present 




491-495 DG+DWJM No Cells Absent 
466-470 DG  No Cells Absent 
481-485 DWJM No Cells Absent 





























1 Wound 98.6 95 98.6 98.6 97.2 97.6 
2 DG 98.04 97.6 98.04 97.6 98.04 97.86 
3 DWJM  94.40 90.87 94.08 87.91 94.71 92.39 
4 DG+DWJM 70.91 16.4 76.04 57.6 17.1 47.61 
5 DG+Undiff WJMSCs 95.47 93.2 93.4 98.04 92.1 
94.44 
6 DWJM+Undiff WJMSCs 67.91 62.35 91.64 94.24 - 
79.03 
7 DG+DWJM+ WJMSCs 94.56 86.10 90.82 80.94 86.31 
87.75 
8 DG+Diff WJMSCs 99.13 99.13 99.13 99.13 97 
98.71 
9 DWJM +Diff WJMSCs 97.72 97.95 96.95 98.72 96.87 
97.64 





Table 8 – Wound healing assessment according to various experimental groups.  


















Cells of  
Human  
Origin 
1 Wound  97.60%     Incomplete + - - - - 
2 DG 97.86% Complete + - - - - 
3 DWJM 92.39% Incomplete + - 
- 
- - 




5 DG+Undiff WJMSCs 94.44% Incomplete + - 
- + + 
6 DWJM+Undiff WJMSCs 79.04% Incomplete + - 












98.71% Complete + 99±7.7 
 





97.64% Incomplete + - 
 





96.73% Complete + 10±3.7 
 
5±1.6 + + 
 
+ Present, - Absent, Complete – complete epithelialization between the wound edges, Incomplete 
– No complete epithelialization between wound edges  
DG- Dermal graft, DWJM – Decellularized Wharton’s jelly matrix, WJMSCs- Wharton’s jelly 




Table 9 - Density of skin appendages according to the experimental groups. 
  Mice 1 Mice 2 Mice 3 Mice 4 Mice 5 Average 
HF SG HF SG HF SG HF SG HF SG HF SG 
1 Wound - - - - - - - - - - - - 
2 DG - - - - - - - - - - - - 
3 DWJM - - - - - - - - - - - - 
4 DG+DWJM - - - - - - - - - - - - 
5 DG+Undiff 
WJMSCs 
- - - - - - - - - - - - 
6 DWJM+Undiff 
WJMSCs 



















9 2 10 5 8 4 9 4 13 4 9.8 3.8 
 
HF- Hair follicle, SG – Sebaceous glands, DG- Dermal graft, DWJM – Decellularized Wharton’s 




Chapter 5: Conclusions and Final Perspective 
The goal of tissue engineering and regenerative medicine is to restore structure and 
function to a defect by utilizing the body’s natural response. These approaches require a 3D bio-
scaffold that can provide the necessary structural support and mimic the natural environment, by 
promoting interaction and integration with the tissue through appropriate physical and cellular 
signals. This work is performed on the hypothesis that decellularized Wharton’s jelly matrix can 
be used as a three dimensional scaffold for culturing MSCs and when provided with the 
necessary cues, will enable their differentiation to the suitable cell types/tissues. This dissertation 
demonstrates a novel way to culture WJMSCs to promote their differentiation towards 
ectodermal lineage. The success of this work would facilitate wound healing by promoting 
complete skin regeneration along with its associated structures such as hair follicles and 
sebaceous glands in full thickness defects from chronic wounds, burns and help in treating 
conditions like alopecia/baldness which are experienced by a large population. 
Human umbilical cords were obtained from consented mothers, after normal vaginal 
delivery, and used for isolating Wharton’s jelly matrix and decellularizing it following a series of 
chemical and osmotic treatments and extraction of Wharton’s jelly mesenchymal stem cells 
(WJMSCs).  Human umbilical cords are typically discarded after delivery and therefore are easy 
to obtain and their use is non-controversial without ethical constraints associated with other 
sources of stem cells. Wharton’s jelly that is extracted and decellularized is called decellularized 
Wharton’s jelly matrix (DWJM). The obtained DWJM is porous, completely devoid of cells, and 
comprised of 0.66 µg/mg of sulfated glycosaminoglycans along with hyaluronic acid, collagen 
and fibronectin. Mass spectrometry also identified a variety of extracellular matrix proteins such 
as collagen types I, II, VI, XII, fibronectin I, and lumican I in DWJM. This matrix demonstrated 
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mechanical properties similar to elastomeric scaffolds and when transplanted in vivo in a mice 
cranial defect, attracted neighboring GFP positive cells as early as 24 hours. When implanted at 
the mice cranial defect, the matrix was degraded after 14 days thus proving to be a biocompatible 
and biodegradable scaffold.  
 The extracted WJMSCs were plastic adherent and positive for markers such as CD73, 
CD90 and CD105 and negative for hematopoietic stem cell markers CD45, CD13, CD14 and 
CD19. As these MSCs are seeded on DWJM, evidence suggests they attach to and penetrate the 
porous matrix when cultured in vitro. WJMSCs were found at various planes along the thickness 
of the matrix and were viable and motile. Thus, this novel three-dimensional scaffold provided 
the necessary mechanical support to promote growth of cells.  
The potential of WJMSC’s to differentiate into bone, cartilage, and fat has been 
extensively researched. Recent evidence suggests that these cells can undergo ectodermal 
differentiation. In this dissertation, WJMSCs were cultured on DWJM in an osteogenic 
differentiation media to promote their ectodermal differentiation and assist in regeneration of 
skin and hair for wound healing applications to treat defects resulting from burns or chronic 
wounds. After 2 weeks of in vitro culture, the differentiated cells formed cellular condensations 
and were positive for cytokeratin-19 (CK19), α-smooth muscle actin (SMA) and collagen 
creating a microenvironment conducive for epithelial (CK19) and mesenchymal (SMA) 
interactions.  The matrix also produced hair-like structures, which were either coiled underneath 
and 10 - 30 µ in length or straight, 30 – 100 µ wide and protruding out.  The potential of other 
MSC’s such as bone marrow mesenchymal stem cells (BMMSCs) to produce these hair-like 
structures was also investigated. We observed that BMMSCs did not possess such potential.  
WJMSCs were also cultured on an acellular dermal graft (Alloderm®) (DG) in osteogenic media 
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and differentiated to similar CK19, SMA and collagen positive cells but hair like structures were 
not observed. The components of osteogenic differentiation media were explored and it was 
noted that while dexamethasone was dispensable, β-glycerophosphate, vitamin C and vitamin D 
might be playing an important role in ectodermal differentiation.  
We also investigated well-known pathways essential for hair follicle formation and 
showed that the up regulation of β-catenin gene and the lower expression of BMP4 gene were the 
key players in our model. β-catenin is the early signal responsible for hair follicle formation and 
is accompanied by higher expression of noggin, a BMP4 inhibitor. In our model we show that, at 
week 2, WJMSCs cultured on DWJM in osteogenic media exhibited an increase in β-catenin 
expression followed by an up regulation of noggin mRNA, while BMP4 mRNA expression was 
undetectable. On the other hand, in BMMSCs, BMP4 mRNA was detected at significant levels, 
which we believe plays a role in their inability to differentiate to hair-like structures.  
Finally, the potential of these in vitro generated hair-like structures and associated cells 
that are CK19 and SMA positive to develop hair follicles and regenerate epithelial tissue was 
investigated in vivo using C57BL/6J mice. A 1.5 X 1.5 cm full thickness excisional skin wound 
was made on the back of the mice and DG/DWJM/ DG+DWJM grafts were transplanted with 
osteogenic undifferentiated or differentiated WJMSCs. After 2 weeks, it was observed that the 
mice with DG and differentiated WJMSCs, and mice with DG+DWJM and differentiated 
WJMSCs cells, achieved 98.71% and 96.73% wound healing, respectively. These groups 
completely regenerated the epidermis along with the associated appendages such as hair follicles 
and sebaceous glands although, the quantity of these appendages was observed to be higher in 
mice with DG and differentiated cells alone. Hair regeneration was mice own hair, suggesting 
that observed effect was probably related to paracrine effects produced by the transplanted 
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differentiated WJMSCs. This observation should be further investigated to optimize wound 
healing.   
Interestingly, the presence of DWJM in the wound bed prevented wound healing by 
contraction in the presence of undifferentiated cells or in the case when DWJM was used alone. 
Cells were noted to have migrated into the lower region of DWJM that was in contact with 
wound; however, there was no cellular infiltration towards the outer exposed surface. This could 
possibly be due to the thickness of graft that might have limited the essential nutrient supply to 
the uppermost layers to support cellular infiltration and proliferation.  
One of the inadequacies of this work has been difficult to obtain uniform DWJM 
scaffolds. Wharton’s jelly is a mucoid, porous, gelatinous connective tissue, which is smooth and 
slippery and very difficult to manually alter the height, width or thickness of the matrix. 
Although care was taken to keep the scaffolds at 7mm diameter and 2mm thickness, attaining 
uniform scaffolds was challenging.  Also, it was also difficult to fully utilize the complete 
Wharton’s jelly matrix as a large portion was wasted due to the circular shape and also the non-
uniformity in the various cords used in these studies. Procuring larger scaffolds such as 1.5 X 1.5 
cm was difficult, thus several smaller pieces were sewn together using sutures. The variations in 
the animal studies between the groups can be attributed to the differences in compositions of 
different umbilical cords from individuals of diverse age groups and ethnicity.  Therefore, 3D bio 
printing is an option for future engineers or scientists working on this model. If Wharton’s jelly 
matrix can be lyophilized into powder form, it might be possible to 3D print the scaffolds in 
required shapes and dimensions. Multiple cords can be processed to obtain enough material with 
the desired quantity that can be combined together to eliminate the sample-to-sample variation. 
Scaffolds can be tailored to enhance the applications and the best possible scaffold for wound 
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regeneration and appendage formation can be constructed and tested. This also gives an 
opportunity to customize the scaffold according to patient needs since all injuries present a 
unique challenge.  
Another area for future research is to isolate CK19 and SMA positive cells and transplant 
them directly at the wound site to evaluate healing. It would be remarkable to see if these cells 
have the potential to survive at the wound site and promote wound healing independent of 
DWJM or dermal graft.   
Finally, this thesis presents a novel way to promote ectodermal differentiation of 
WJMSCs to CK19 and SMA positive cells, aiding in wound healing and skin regeneration. 
Perhaps, most importantly, the work presented here has shown a way to bridge the gap between 
the bench and bedside, by examining the transplantation of in vitro generated cells in mice. This 
study can be extended further and the potential of these cells in wound healing and hair follicle 
formation can be explored in other animal models. If proven successful, our model can be 
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